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Abstract
The plant hormones brassinosteroid (BR) and gibberellin (GA) have important roles in a wide
range of processes involved in plant growth and development. In this paper we derive and analyse
new mathematical models for the BR signalling pathway and for the crosstalk between the BR and
GA signalling pathways. To analyse the effects of spatial heterogeneity of the signalling processes,
along with spatially-homogeneous ODE models we derive coupled PDE-ODE systems modelling
the temporal and spatial dynamics of molecules involved in the signalling pathways. The values of
the parameters in the model for the BR signalling pathway are determined using experimental data
on the gene expression of BR biosynthetic enzymes. The stability of steady state solutions of our
mathematical model, shown for a wide range of parameters, can be related to the BR homeostasis
which is essential for proper function of plant cells. Solutions of the mathematical model for the
BR signalling pathway can exhibit oscillatory behaviour only for relatively large values of param-
eters associated with transcription factor brassinazole-resistant1’s (BZR) phosphorylation state,
suggesting that this process may be important in governing the stability of signalling processes.
Comparison between ODE and PDE-ODE models demonstrates distinct spatial distribution in the
level of BR in the cell cytoplasm, however the spatial heterogeneity has significant effect on the
dynamics of the averaged solutions only in the case when we have oscillations in solutions for at
least one of the models, i.e. for possibly biologically not relevant parameter values. Our results for
the crosstalk model suggest that the interaction between transcription factors BZR and DELLA
exerts more influence on the dynamics of the signalling pathways than BZR-mediated biosynthesis
of GA, suggesting that the interaction between transcription factors may constitute the principal
mechanism of the crosstalk between the BR and GA signalling pathways. In general, perturba-
tions in the GA signalling pathway have larger effects on the dynamics of components of the BR
signalling pathway than perturbations in the BR signalling pathway on the dynamics of the GA
pathway. The perturbation in the crosstalk mechanism also has a larger effect on the dynamics
of the BR pathway than of the GA pathway. Large changes in the dynamics of the GA signalling
processes can be observed only in the case where there are disturbances in both the BR signalling
pathway and the crosstalk mechanism. Those results highlight the robustness of the GA signalling
pathway.
Key words. plant modelling; hormone crosstalk signalling; homeostasis in plants; stability analysis
and Hopf bifurcation; PDE-ODE systems
AMS subject classification. 34Cxx, 35Q92, 65Nxx, 92Bxx, 92Cxx
1 Introduction
The sessile nature of plant life highlights the importance of efficient regulatory mechanisms allowing
plants to respond to environmental stimuli and to adapt to changing environmental conditions. Plants
have developed a set of highly integrated signalling pathways. Plant hormones, e.g. auxin, gibberellin,
cytokinin, brassinosteroids, ethylene, are key signalling molecules and their activities depend on the
cellular context and interactions between them.
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The family of steroidal plant hormones brassinosteroids (BRs) is responsible for the regulation and
control of a wide range of essential processes including responses to stresses [7, 23], photomorphogen-
esis [8, 67], root growth [38], and stomatal development [27]. Over the last 47 years, the effects of
brassinosteroids on plant cells and plants as a whole, as well as their signalling pathways have been
studied in detail [14]. In particular the signalling pathway of brassinolide (BL), the most biologically
active of the discovered BRs, has been examined in great detail, and is now one of the most understood
pathways in plant biology [8, 13, 28, 30, 44, 63, 64, 66, 67]. BR signalling functions by controlling the
expression of various genes regulating developmental processes, of which 1000s have been identified
[49], including several genes which regulate the production of proteins that act as enzymes during BR
biosynthesis [50]. To ensure controlled growth, homeostasis of BRs in plant tissue is carefully main-
tained by negative feedback in the BR signalling pathway [50]. Absence of BRs and/or perturbed BR
signalling have also been linked to many growth defects, including dwarfism and male sterility [12, 15].
Gibberellins (GAs) are another family of plant hormones involved in many developmental processes
in plants, including seed germination, stem elongation, leaf expansion, trichrome development, pollen
maturation and the induction of flowering [2, 17]. There are over 130 categorized gibberellins, a few
of which are bioactive molecules, the most common being GA1, GA3 and GA4 [65].
Along with detailed information on individual plant hormone signal transduction pathways, their
target genes, and their effects, it is now also known that interactions between various molecules in-
volved in different signalling pathways have an effect on physiological phenomena in plants [6, 8]. For
example both auxin and brassinosteroids play a role in the patterning of vascular shoot bundles [25],
as well as exhibiting some cross-regulation of biosynthesis via the BRX gene [43]. The GA signalling
pathway exhibits a high level of interaction with the BR signalling pathway regulating growth [15, 54]
and responses to stresses [2, 7] among others. The interactions between different signalling pathways
are called crosstalks, and the investigation of their mechanisms is key to better understand plant
hormonal responses to external stimuli [4, 8, 23, 66]. Despite the need for better understanding of
the mechanisms of crosstalk between hormone signalling pathways, it is hard to obtain experimentally
quantitative data on the dynamics of all molecules involved in the signalling pathways and interactions
between them. For example, it is very difficult to measure the dynamics of hormones such as BR in
real time, in part due to their occurring naturally at extremely low levels. Therefore development
of accurate mathematical models of hormone activity can help to analyse and better understand in-
teractions between signalling pathways and their impact on plant growth and development. Hence,
the main aim of this paper is to derive and analyse novel mathematical models for the BR signalling
pathway, and the crosstalk between the BR and GA signalling pathways.
Along with many modelling results for the gibberellin and auxin signalling pathways [22, 34, 35, 36, 37],
only a few models can be found for BR-related signalling processes. A logic model for the activation
states of the components of the BR and auxin signalling pathways and their interactions was derived in
[43], and provided a qualitative description of the dynamics of the BR pathway. In a simple model for
BR-mediated root growth, proposed in [58], the growth dynamics is assumed to be dependent on the
quantity of receptor-bound BL, which was considered to be constant. A system of ordinary differential
equations was considered to describe the dynamics of BR-regulated transcription factor BES1 (BRI1-
EMS SUPRESSOR 1) and its interactions with R2R3-MYB transcription factor BRAVO, related to
division of plant stem cells [19, 60]. To our knowledge there are no previous results on mathematical
modelling of the crosstalk between BR and GA signalling pathways.
In our mathematical model for the BR signalling pathway, we consider the dynamics of BR, free
and bound receptors, inhibitors, and phosphorylated and dephosphorylated transcription factors, not
considered in previous models. The spatially homogeneous dynamics of the molecules involved in the
signalling pathway that we consider are modelled by a system of six ordinary differential equations
(ODEs). To analyse the effect of spatial heterogeneity of the signalling processes on the dynamics of
BR, we derive a coupled model composed of partial differential equations (PDEs) for BR, inhibitor,
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and phosphorylated transcription factor, ODEs for receptors, defined on the cell membrane, and the
ODE for dephosphorlyated transcription factors, localised in the cell nucleus. Along with spatial dis-
tribution of the concentration of BR in the cell cytoplasm, we observe similar dynamics for solutions of
the ODE and averaged solutions of the PDE-ODE models when those solutions converge to a steady
state as t → ∞. However spatial heterogeneity has significant effect in the case when at least one
of the two models has periodic solutions, which is determined for possibly biologically not relevant
parameter values.
To model the crosstalk between BR and GA signalling pathways we first rigorously derive a reduced
model for the GA signalling pathway from the full GA signalling pathway model proposed in [36]. Then
we couple the model for the BR signalling pathway with the reduced model for GA signalling pathway
by considering three different interaction mechanisms between BR and GA pathways. By analysing
the effect of different interaction mechanisms on the dynamics of molecules involved in the signalling
processes, we determine that one of these mechanisms has a more significant effect on the dynamics
of the signalling pathways than the other mechanisms. Similar to the BR signalling pathway model,
we also consider the influence of spatial heterogeneity of the signalling processes on the dynamics of
solutions of the BR-GA crosstalk model. Using the mathematical models developed here, we analyse
how interactions between the BR and GA signalling pathways depend on the model parameters and
the strength of interaction mechanisms. We observed that, in general, parameter changes in both
pathways have a stronger effect on the components of the BR signalling pathway than on the compo-
nents of the GA signalling pathway. Our results also suggest that the interaction between transcription
factors exerts more influence on the dynamics of the signalling pathways than BR signalling-mediated
GA biosynthesis. Further, our results suggest that perturbations in the GA signalling pathway have
larger effects on the dynamics of components of the BR signalling pathway than the perturbations in
the BR signalling pathway on the dynamics of components of the GA signalling pathway, apart from
in the case when we have disturbances in both the BR signalling pathway and the crosstalk mechanism.
The structure of this paper is as follows. In Section 2 a biological overview of the BR and GA
signalling pathways, and their interactions is given. In Section 3 we derive the mathematical model
for the BR signalling pathway and estimate the values for the model parameters using experimental
data from [50]. In Section 4 we perform qualitative analysis of the model for the BR signalling path-
way, examining how the behaviour of solutions of the mathematical model depends on the values of
the model parameters. We also define the set of parameters for which the system of ODEs has stable
stationary solutions and the set of parameters for which it undergoes Hopf bifurcation. In Section 5
we extend our model for the BR signalling pathway to examine the effects of spatial heterogeneity
in the signalling processes. In Section 6 we consider the reduction of the mathematical model for
the GA signalling pathway, proposed in [36], derive a new model for the crosstalk between BR and
GA signalling pathways, and analyse the influence of different interaction mechanisms and changes in
the dynamics of one of the signalling pathways on the qualitative and quantitative behaviours of the
coupled system. We also analyse the influence of spatial heterogeneity of the signalling processes on
the interactions between the BR and GA signalling pathways. We summarise and discuss our results
in Section 7.
2 Biological Background
The mathematical modelling and analysis of the BR signalling pathway and of the interactions between
the BR and GA signalling pathways is the main aim of this paper. In this section we present an
overview of the BR and GA signalling pathways, and the interactions between them.
2.1 The BR Signalling Pathway
The signalling process starts at the cell plasma-membrane with the perception of BR by the re-
ceptor BRASSINOSTEROID INSENSITIVE1 (BRI1) [29]. Upon BR binding to BRI1, two main
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events then take place, association of BRI1 to a co-receptor, BRI1-ASSOCIATED RECEPTOR KI-
NASE1 (BAK1), and dissociation of the inhibitor protein BRI1 KINASE INHIBITOR1 (BKI1). This
triggers a transphosphorylation cascade between BRI1 and BAK1, leading further to phosphoryla-
tion of BRASSINOSTEROID-SIGNALLING KINASE1 (BSK1), another membrane-bound kinase.
Next, BSK1 phosphorylates the protein phosphatase BRI1-SUPPRESSOR1 (BSU1), which dephos-
phorylates a protein kinase BRASSINOSTEROID INSENSITIVE2 (BIN2), eventually leading to its
degradation [41]. In the absence of BR, phosphorylated BIN2 has a role in phosphorylating the
two transcription factors, BRASSINAZOLE RESISTANT1 (BZR1) and BRI1-EMS-SUPPRESSOR1
(BES1) [30], also known as BZR2 (for the purposes of this paper it is unnecessary to distinguish
between the two, so we refer to them jointly as BZR). When phosphorylated, BZR is less stable and
thus more unlikely to activate or repress any of the 1000s of genes associated with BR signalling [42],
it is also thought that association of phosphorylated BZR to a 14-3-3 protein inhibits its entry to the
nucleus. PROTEIN PHOSPHOTASE 2A (PP2A) is responsible for the de-phosphorylation of BZR,
which allows its entry into the nucleus and then its activation of BR responsive genes.
BZR functions as a repressor of certain genes associated with the biosynthesis of BR, notably for ex-
ample CONSTITUTIVE PHOTOMORPHOGENESIS AND DWARFISM (CPD), DWARF4 (DWF4),
ROTUNDIFOLIA3 (ROT3) and BRASSINOSTEROID-6-OXIDASE 1 (BR6ox1) [50]. That is, active,
de-phosphorylated BZR inhibits production of BR. So, high levels of BR cause low levels of phospho-
rylated BZR, leading to inhibition of BR biosynthesis and decreasing levels of BR. Conversely, low
levels of BR lead to high levels of phosphorylated BZR and activation of BR biosynthesis, increasing
the levels of BR. This completes the negative feedback loop of the BR signalling pathway.
2.2 The GA Signalling Pathway
Gibberellin Signalling is achieved by enhancing the degradation of DELLA proteins, which influence
the expression of GA-responsive genes [1]. GA molecules are perceived by the GA receptor, GIB-
BERELLIN INSENSITIVE DWARF1 (GID1), a nuclear-localised protein [55]. Analysis of GID1’s
structure revealed that it has a GA-binding pocket, with a flexible extension adjacent [45]. When GA
binds to GID1, this extension undergoes conformational change, and covers the GA-binding pocket.
When closed, the upper surface of this lid binds to DELLA proteins to form the GA.GID1.DELLA
complex. The formation of the GA.GID1.DELLA complex enhances the degradation of DELLA pro-
teins by mediating proteasome-dependent destabilization of DELLA proteins.
The GA signalling pathway exhibits negative feedback due to the influence of DELLAs on the ex-
pression of several genes which code components of the signalling pathway [65]. First, DELLA acti-
vates the GID1-encoding gene, leading to an increase in the translation of the GID1 protein. This
means that in the absence of DELLAs, GID1 concentration also decreases which will slow down the
proteasome-induced DELLA degradation, and that an abundance of DELLA leads to the production
of more GID1 and enhances the DELLA degradation. Next, DELLA activates the transcription of
genes encoding the enzymes GA 20-oxidase (GA20ox) and GA 3-oxidase (GA3ox). These enzymes
catalyse several reaction steps in the GA biosynthesis pathway, meaning an abundance of DELLA
increases both GA and GID1, leading to degradation of DELLA. Lastly, DELLA represses its own
gene transcription.
2.3 Crosstalk between the BR and GA Signalling Pathways
The interaction of BRs and GAs has been receiving much attention, due to their shared nature as
critical plant growth regulators, combined with the fact that they share many overlapping functions
such as regulation of cell elongation [10, 54] and plant responses to abiotic stress [3, 16]. However
despite the interest, the exact mechanisms of these interactions have remained largely unclear, save
from the fact that they control expression of several genes [9]. There has been much evidence that
the signalling processes of BR and GA converge at the level of BZR and DELLA interaction. Direct
crosstalk in this fashion was shown in [32], where it was shown that overexpression of DELLA proteins
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reduced both the abundance and transcriptional activity of BZR. This was found to be due to the
formation of a complex of DELLA and BZR, which removed BZR’s transcriptional ability. There
is also evidence of BRs regulating the biosynthesis of GAs, the so called “GA Synthesis” model of
BR-GA crosstalk. Two main proposals have been made for the existence of this type of interaction.
The effects of BR mutants on GA synthesis were examined in [53], and it was concluded that BZR
enhances GA synthesis by activating synthesis of the GA3ox enzyme. In contrast to this the findings
in [56] describe a much larger role for BZR in regulating GA synthesis. They provide evidence for a
model where BZR activates the synthesis of the GA20ox enzyme, in addition to the effects described
in [53]. Thus BZR would influence the biosynthesis of GA in exactly the same manner as DELLAs
for other interactions, however the significance of this mechanism of crosstalk is not yet established
[40, 52, 57].
3 Derivation of a Mathematical Model for the BR Signalling Path-
way
In this section we derive a mathematical model of the BR signalling pathway. In order to build a
simple, yet sufficiently accurate and efficient model incorporating BR biosynthesis negative feedback,
we first construct a reduced reaction schematic that describes the pathway mechanism. This reduc-
tion is achieved via a simplification of two principal parts of the signalling pathway: the complex BR
biosynthesis network, and the cytoplasm localized phosphorylation cascade. Hence, we build a model
focussing on three key components, hormone (BR), inhibitor (BKI1) and transcription factor (BZR),
Fig. 1.
In the mathematical model we consider the binding of free BR molecules to the BRI1 receptors
leading to the dissociation of BKI1. This is modelled as an almost instantaneous reaction, with BR
+ BRI1.BKI1 interacting and resulting into BR.BRI1 + BKI1. In order to model the effects of the
signalling cascade induced by the membrane-bound receptors and subsequent effects on the phospho-
rylation state of BZR, we assume that the effects of active receptors in triggering the cascade may
be approximated by the free BKI1 that is released upon this activation. We further assume that the
free BKI1 catalyses dephosphorylation of BZR-p and destabilises the BIN2 proteins, thus reducing
the phosphorylation of BZR.
BR + BRI1.BKI1 BR.BRI1 + BKI1 BZR BZR-p
∅
βb
βk
ρz
δz
αb
µb
Figure 1: Reaction schematic of the reduced BR signalling pathway.
We denote by b the concentration of hormone BR, by k the concentration of inhibitor BKI1, by rk the
concentration of receptor-inhibitor complex BRI1.BKI1, by rb the concentration of receptor-hormone
complex BR.BRI1, by z the concentration of (dephosphorylated) transcription factor BZR, and by zp
the concentration of (phosphorylated) transcription factor BZR-p. Then assuming spatial homogeneity
of the signalling processes, the interactions between b, k, rk, rb, z, and zp are described by the system
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of six ordinary differential equations
db
dt
= βkrbk − βbrkb+ αb
1 + (θbz)hb
− µbb,
dk
dt
= βbrkb− βkrbk,
drk
dt
= βkrbk − βbrkb,
drb
dt
= βbrkb− βkrbk,
dz
dt
= δzzpk − ρz z
1 + (θzk)hz
,
dzp
dt
= −δzzpk + ρz z
1 + (θzk)hz
.
(1)
Here βb is the binding rate of b to rk, and βk is the binding rate of k to rb. We model this as only
two reactions by assuming that when either BR or BKI1 are bound to BRI1 either dissociates suffi-
ciently fast that the levels of the BR.BRI1.BKI1 remains roughly zero. We assume the reaction to
occur in some finite closed volume, so the loss of BR is only described by the degradation coefficient µb.
The phosphorylation state of BZR is modelled as being dependent on the levels of free BKI1. We
justify this by noting that upon signalling activation, the receptor phosphorylates BSU1 which gov-
erns the phosphorylation of BZR via BIN2. Thus since BKI1 is also released upon BR binding, we
may model these effects by assuming that free BKI1 activates (or catalyses) the dephosphorylation of
BZR-p at rate δz. In BKI1’s absence BZR is phosphorylated at rate ρz, and when BKI1 is present
it inhibits the phosphorylation of BZR such that when k = 1/θz, the rate of phosphorylation is halved.
Finally we model BR biosynthesis as being directly inhibited by BZR. BZR represses the expres-
sion of several genes encoding enzymes, namely CPD, DWF4, ROT3 and BR6ox1, that are required
for the conversion of many of the precursors involved in BR biosynthesis. Hence we use a Hill function
with exponent hb > 1 to model the cumulative inhibitory effect of BZR on these genes. We estimate
the parameter hb by considering the detailed BR biosynthesis pathway(s) presented in [11]. The BR-
mediated enzymes that are involved in the biosynthesis are CPD, DWF4, ROT3, and BR6ox1 which
mediate four, five, six, and five steps in the biosynthetic pathway respectively. Since BR biosynthetic
enzymes act multiplicatively at different steps of the reaction network, the expressions modelling their
actions can be approximated by the product of these expressions, which would mean that the expo-
nents of these functions would be summed, thus we consider hb = 20.
The model equations (1) imply that the total concentrations of BKI1, BRI1 and BZR are conserved,
thus we consider k + rk = Ktot, rb + rk = Rtot, and z + zp = Ztot, and derive a reduced model:
db
dt
= βk(Rtot −Ktot + k)k − βb(Ktot − k)b+ αb
1 + (θbz)hb
− µbb,
dk
dt
= βb(Ktot − k)b− βk(Rtot −Ktot + k)k,
dz
dt
= δz(Ztot − z)k − ρz z
1 + (θzk)hz
.
(2)
Various values for Rtot were reported in [59], and we chose the value for WT seedling roots. We further
assume that Ktot = Rtot in order that the receptor should have the ability to be completely inactive,
but not be saturated by BKI1. We also use physiological values reported in the literature in order
to write βk and µb in terms of other parameters, for full calculations see A. As such we are left with
8 parameters for which we have no direct estimate, namely βb, αb, θb, δz, Ztot, ρz, θz and hz. These
parameters were estimated indirectly by validating the numerical solutions of the mathematical model
(2) against experimental results, using numerical optimisation algorithms.
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By deriving the steady state concentration of BR, denoted [BR]0, from the level of endogenous 24-
epiBL reported in [62], we were able to write the rate of BR degradation µb in terms of αb, θb, Ztot,
δz, ρz, θz, hz and hb as follows
µb =
αb
[BR]0
(
1 +
(
θb
Ztotδz [BKI1]0(1+(θz [BKI1]0)hz )
ρz+δz [BKI1]0(1+(θz [BKI1]0)hz )
)hb) . (3)
We can write βk in terms of βb and other known parameters in two ways. First, using [BR]0 in
conjunction with the dissociation constant of BR.BRI1, denoted Kd, reported in [64] we can estimate
the steady state concentration of BKI1, denoted [BKI1]0, and write βk in terms of [BR]0, [BKI1]0,
Ktot, Rtot, and βb as follows
βk =
(Ktot − [BKI1]0)[BR]0
(Rtot −Ktot + [BKI1]0)[BKI1]0βb, (4)
by assuming that the dissociation constant for BR.BRI1 depends on the steady state concentrations
of BR, BR.BKI1 and BR.BRI1. For the second expression we considered the dissociation of both BR
and BKI1 from BR.BRI1.BKI1, using the value for the dissociation constant of BKI1, denoted Km,
reported in [61], as well as Kd, to directly write βk in terms of βb as
βk =
Kd
Km
βb. (5)
These two constraints (4) and (5) on βk correspond to two different mechanisms for the interactions
between BR, BRI1 and BKI1. In (4) binding of BR to BRI1.BKI1 causes instantaneous dissociation
of BKI1 and formation of BR.BRI1, likewise binding of BKI1 to BR.BRI1 causes instantaneous disso-
ciation of BR and formation of BRI1.BKI1. In (5) binding of BR to BRI1.BKI1 or binding of BKI1 to
BR.BRI1 leads to the formation of BR.BRI1.BKI1, which may then dissociate into either BKI1 and
BR.BRI1, or BR and BRI1.BKI1. Model (2) was fitted to experimental data using both conditions
(4) and (5) in order to compare their effects, see Figs. 2 and 3.
The experimental data from [50], used to determine model parameters, give the relative BR biosyn-
thetic gene expression of CPD, DWF4, ROT3, and BR6ox1, and were measured by RT-PCR analysis,
then converted to give relative values with the initial values equal to one. Values were measured
for three independent experiments (three replicates), and the data presented by points and (where
available) error bars correspond to the mean and standard error respectively. Gene expression was
measured in both Wild-Type (WT) and bri1-401 mutant (where perception of BR by BRI1 is inhib-
ited) plants, and this was accounted for in our parameter estimation by assuming that the parameter
βb was greater for the WT than for the mutant. βk was allowed to vary freely for the mutant case
since constraints (4) and (5) are not definitely valid in this case. Both of these phenotypes were grown
under control conditions as well as two other cases: one where plants were grown in a medium con-
taining 5 µM of Brassinazole (BRZ), a BR-specific biosynthesis inhibitor, and one grown in a medium
containing 0.1 µM of Brassinolide (BL) having first been grown in the medium containing 5 µM BRZ
for two days. Data comparing the control case with the case of growth in the 5 µM BRZ medium were
recorded for five days. Data comparing further growth after two days of the BRZ medium case with
the case of addition of 0.1 µM BL to the medium were recorded for further 24 h, and as such for these
cases the initial conditions were taken to be the values of the numerical solution to the model for the
5 µM BRZ medium at time t = 2 days. For the control conditions we made no amendments to the
model, for the case of plants growing in the BRZ-medium we imposed bounds upon the parameters
such that αb should be smaller in this case since addition of BRZ reduces the biosynthesis of BR. In
order to examine the case where BL was added to the growth medium, an extra term governing influx
of exogenous BL and efflux of endogenous BR was added to the equation describing BR dynamics
db
dt
= βk(Rtot −Ktot + k)k − βb(Ktot − k)b+ αb
1 + (θbz)hb
− µbb+ φb(ωb − b),
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where φb is the relative permeability of the cell membrane to BR and was one of the optimised pa-
rameters for the relevant cases, and ωb is assumed to be 0.1 µM in accordance with the experimental
procedure.
Optimisation was achieved by comparing the biosynthetic expression defined by the numerical so-
lutions of model (2), the term 1/(1 + (θbz)
hb), with experimental data presented in [50]. In order to
compare experimental data with the output from our model we first normalised the simulation data by
their initial values such that they took values comparable to the experimental data. We then took the
mean of the four gene data sets, weighted by the number of times the respective proteins appear in the
biosynthetic pathway. The optimisation was carried out in Python using the curve_fit function in
the SciPy module [26]. curve_fit applies nonlinear least squares minimization using the trust region
reflective algorithm as default, with a default tolerance of 10−8. The model was fitted to the data set
for each case sequentially, starting with the WT under control conditions since this data set was the
largest. The parameters µb and βk were replaced by the expressions (3) and (4) or (5), respectively,
for the WT data under control conditions since this is the only case where such parameter constraints
are definitely valid. The parameters generated from the fitting for WT under control conditions were
then used as the initial guesses for all other cases, where µb and βk were also allowed to be fitted.
Parameters that were not expected to vary under the different growth conditions were allowed very
small variations to account for error in the first fitting, whereas parameters that were expected to vary
had much wider bounds.
Numerical simulations of model (2) using the optimised parameters, given in Tables 1 and 2 for
βk determined by (4) and (5) respectively, are plotted against the experimental data in Fig. 2 and 3
and show good agreement with experimental data, having R2 values of 0.89 and 0.92 respectively.
Constant Value Units Source Constant Value Units Source
αb 0.27 µM min
-1 fit θz 3.95 µM
-1 fit
βb 8.33 µM
-1 min-1 fit hb 20 [11]
βk 2.73 µM
-1 min-1 (4) hz 6 fit
ρz 1.33× 10−4 min-1 fit Ktot 6.2× 10−2 µM fit
δz 1.02× 10−3 µM-1 min-1 fit Rtot 6.2× 10−2 µM [59]
µb 3.58 min
-1 (3) Ztot 2.65 µM fit
θb 1.96 µM
-1 fit φb 7.06 min
-1 fit
ωb 0.1 µM [50]
Table 1: The model parameters associated with the BR signalling pathway model (2) for WT when
fitted using expression (4) for βk, together with their sources (Parameter set 1).
4 Qualitative Analysis of the Mathematical Model for the BR Sig-
nalling Pathway
In this section we consider well-posedness and qualitative analysis of model (2). We start by non-
dimensionalising our model, transforming the variables as t = 1µb t¯, b =
αb
µb
b¯, k = Ktotk¯, z = Ztotz¯, and
introducing the dimensionless parameters
β¯k =
βkK
2
tot
αb
, β¯b =
βbKtot
µb
, κ =
Rtot
Ktot
, θ¯b = θbZtot,
 =
αb
Ktotµb
, δ¯z =
δzKtot
µb
, ρ¯z =
ρz
µb
, θ¯z = θzKtot,
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Constant Value Units Source Constant Value Units Source
αb 0.27 µM min
-1 fit θz 3.95 µM
-1 fit
βb 8.33 µM
-1 min-1 fit hb 20 [11]
βk 2.18× 10−2 µM-1 min-1 (5) hz 6 fit
ρz 4.26× 10−4 min-1 fit Ktot 6.2× 10−2 µM fit
δz 1.75× 10−3 µM-1 min-1 fit Rtot 6.2× 10−2 µM [59]
µb 3.68 min
-1 (3) Ztot 2.68 µM fit
θb 2.0 µM
-1 fit φb 160.93 min
-1 fit
ωb 0.1 µM [50]
Table 2: The model parameters associated with the BR signalling pathway model (2) for WT when
fitted using expression (5) for βk, together with their sources (Parameter set 2).
Figure 2: BR biosynthetic gene expression calculated from the numerical solutions of model (2),
plotted against experimental data from [50]. For the WT plants grown under control conditions the
parameters given in Table 1 were used, parameter sets for other cases can be found in Table 6.
which yields the system (neglecting s)
db
dt
= f1(b, k, z) = βk(κ− 1 + k)k − βb(1− k)b+ 1
1 + (θbz)hb
− b,
dk
dt
= f2(b, k, z) =
1

(βb(1− k)b− βk(κ− 1 + k)k) ,
dz
dt
= f3(b, k, z) = δz(1− z)k − ρz z
1 + (θzk)hz
.
(6)
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Figure 3: BR biosynthetic gene expression calculated from the numerical solutions of model (2),
plotted against experimental data from [50]. For the WT plants grown under control conditions the
parameters given in Table 2 were used.
For simplicity of presentation we denote by P ⊂ [1,∞) × R7+ × N2 the parameter space for system
(6), where for each p ∈ P , p = (κ, βk, βb, θb, , δz, ρz, θz, hb, hz). We assume that κ has a minimum
value of 1 since κ < 1 would imply saturation of receptor by inhibitor (i.e. Ktot > Rtot), leading to
BR signalling being permanently switched on.
Theorem 1. The system (6) has a unique, global solution (b, k, z) ∈ C1([0,∞)) for any initial value
(b0, k0, z0) ∈ [0, 1 + βkκ]× [0, 1]2, and (b(t), k(t), z(t)) ∈ [0, 1 + βkκ]× [0, 1]2 for all t ∈ [0,∞) and any
p ∈ P .
Proof. Define u = (b, k, z)T and f = (f1, f2, f3)
T , and hence dudt = f. Since f is locally Lipschitz-
continuous, the Picard-Lindelo¨f theorem ensures local existence of a unique solution of (6), see e.g. [5].
To obtain global existence and uniqueness we prove boundedness of solutions by demonstrating the
existence of a positive-invariant region for system (6), i.e. showing that for a solution u of (6) starting
in M = [0, 1 + βkκ] × [0, 1] × [0, 1] it will always be contained within this region. To show that a
region M is positive invariant under the flow of system (6), we show that f(u) ·n(u) ≥ 0∀u ∈ ∂M , see
e.g. [5], where n is the inward normal vector on ∂M , see B.1 for more details. This implies uniform
boundedness of solutions of (6) with initial values in M , and continuous differentiability of f ensures
global existence and uniqueness.
Theorem 2. For any parameter set p ∈ P , there exists a unique steady state solution (b∗, k∗, z∗) ∈M
of system (6).
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Proof. Considering equations for a steady state solution (b∗, k∗, z∗) of (6) and employing simple alge-
braic manipulation, k∗ is defined as a root of the following non-linear function
g(k∗) : = βk (κ− 1 + k∗) k∗
1 +( θbδzk∗ (1 + (θzk∗)hz)
ρz + δzk∗ (1 + (θzk∗)hz)
)hb
− βb (1− k∗) ,
and b∗ and z∗ are determined as functions of k∗, for more details see B.2. We may immediately see,
since g(0) = −βb and g(1) = βkκ(1 + (θbδz(1 + θhzz )/(ρz + δz(1 + θhzz ))hb), that g must contain at least
one root in [0, 1] for any p ∈ P , and hence system (6) must contain at least one steady state solution
in M . In order to find the number of roots of g(k∗) = 0 in [0, 1], consider the derivative of g which
is positive for all p ∈ P and k∗ ∈ [0, 1], see B.2 for the formula for g′(k∗). Thus g is monotonically
increasing. Strict monotonicity of g coupled with existence of at least one root in [0, 1] implies that g
has a unique root in [0, 1], and hence (6) has a unique steady state in M .
4.1 Linearised Stability and Bifurcation Analysis
To study the qualitative behaviour of solutions of mathematical model for BR signalling pathway,
we performed linearised stability analysis for system (6) and analyse the impact of variations in
values of model parameters on the behaviour of solutions of (6). For the parameters obtained via
validation of mathematical model by experimental data, see Tables 1 and 2, steady state solutions of
(6) are linearly stable, with eigenvalues (−3.8764,−0.1508,−0.0009) and (−3.6863,−0.1138,−0.0006)
respectively. Further, stability of steady state solutions is maintained under moderate variations of
all parameters, suggesting that the BR homeostasis is ensured in normally functioning plant cells.
Large variations in δz, ρz, and θz however cause qualitative changes in the behaviour of solutions of
model (2) and can induce oscillatory behaviour, but only in the case when all other parameters are
as in Table 1 and not as in Table 2. We consider δz and ρz as bifurcation parameters because these
parameters directly correspond to processes in the BR signalling pathway, whereas 1/(1 + (θzk)
hz)
is only an approximation for the dynamics of the cytoplasmic phosphorylation cascade. Biologically,
increase of δz could potentially correspond to faster phosphorylation of BSU1 by BAK1, or decrease of
δz corresponding to reduced action of PP2A in dephosphorylating BZR. Further, decrease of ρz could
correspond to BIN2-deficient or insensitive mutants e.g. bes1-D, and increase of ρz could correspond
to BIN2-overexpressing mutants, e.g. bin2. In the bifurcation analysis of system (2) we considered
increased value for the dimensional parameter θz compared to the standard value, Table 1 (i.e. θz =
41.2 µM−1), which was essential to determine the region for parameters δz and ρz where system (6)
undergoes bifurcation. For the value of θz = 3.95 µM
−1 obtained through fitting model solutions to
experimental data, the steady state solution of (6) is linearly stable for a wide range of values of δz
and ρz, i.e. δz, ρz ∈ (0, 50).
Theorem 3. As δz and ρz are continuously varied, system (6) undergoes a Hopf bifurcation.
Proof. We performed linearised stability analysis to determine the parameter subspace for which the
stationary solution of (6) is linearly stable, as well as the range of parameters for which we have
periodic solutions for the model (6).
Using the Jacobian (28) of system (6), evaluated at the steady-state (b∗, k∗, z∗), we calculate the
characteristic equation for the system to be a cubic polynomial of the form λ3 + a2λ
2 + a1λ+ a0 = 0,
where a2, a1 and a0 are all positive, real constants (see B.3). Since the characteristic equation is a
cubic polynomial we obtain that there are only 2 possible sets of eigenvalues, either that they are all
real or that there is one real eigenvalue λ1 and two complex conjugate eigenvalues λ2 and λ3. Further,
since all coefficients have the same sign any real eigenvalue must be negative, specifically zero cannot
be an eigenvalue of J for any parameters of system (6) in P . Together these two facts tell us that in
the case where the eigenvalues are all real, or that the complex conjugate eigenvalues have negative
real part the steady state is stable, and that there is a possible bifurcation point when the two complex
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conjugate eigenvalues cross the imaginary axis, corresponding to a Hopf bifurcation.
We showed numerically that for a closed loop L in (δz, ρz) the system has complex conjugate eigen-
values with zero real parts, Fig. 4, and in the region D enclosed by the loop L the complex conjugate
eigenvalues have positive real part, whereas for (δz, ρz) ∈ (0, 50)2 \ D the real part of the complex
conjugate eigenvalues is negative. Hence the points of the loop L correspond to the bifurcation points
where the stability of stationary solutions of (6) changes. We also showed that at such points the
eigenvalues have non-zero imaginary parts and hence do not pass through the origin, Fig. 5a), which
supports the proof of the fact that zero cannot be an eigenvalue of J , presented above. For this we
designed a scheme in MATLAB to calculate the eigenvalues of the Jacobian J in (28), for values of
(δz, ρz) ∈ (0, 50)2, with dimensional parameter values θz = 41.2 µM−1 and all other parameters as
in Table 1. For each δz ∈ (0, 50), we determined the values of ρz ∈ (0, 50) for which J has a pair of
non-zero purely imaginary eigenvalues. The derivatives of the real part of the eigenvalues w.r.t. both
δz and ρz were also calculated numerically, Fig. 5b). The values of
d
dδz
Re(λ2,3) and
d
dρz
Re(λ2,3) at
the critical points are non-zero, apart from exactly four points on the curve in Fig 5b), where the
derivative w.r.t. one of the parameters will be zero. Those four points correspond to the points where
δz or ρz are at their extreme values, i.e. when δz takes an extreme value we have that
d
dρz
Re(λ2,3) = 0,
and when ρz takes an extreme value that
d
dδz
Re(λ2,3) = 0. When δz is fixed at an extreme point,
varying ρz will not cause the point to enter the region bounded by the curve and will not correspond
to a bifurcation point w.r.t. ρz, similar for ρz fixed at an extreme point. Hence zero derivative at this
point does not break the transversality condition. Thus, in conjunction with Theorems 1 and 2 we
have shown that system (6) satisfies all conditions for the existence of a local Hopf bifurcation [24].
Figure 4: Critical dimensional values δz and ρz, at which the complex conjugate pair of eigenvalues
λ2, λ3 of (28) are purely imaginary, form a closed curve L. Note the third eigenvalue λ1 is always
negative. The system (6) exhibits oscillatory behaviour when values of (δz, ρz) are located within the
region D bounded by curve. For δz = 6 fixed, the eigenvalues cross the imaginary axis at ρ(1)z = 3.78
and ρ
(2)
z = 24.1 with values of
d
dρz
Re(λ2,3) of 1.78 × 10−3 and −4.53 × 10−4 respectively. For ρz = 6
fixed, the eigenvalues cross the imaginary axis at δ
(1)
z = 3.14 and δ
(2)
z = 8.87 with values of
d
dδz
Re(λ2,3)
of 2.73× 10−3 and −1.33× 10−3 respectively.
Therefore, for all parameter sets such that (δz, ρz) ∈ (0, 50)2 \ D, θz = 41.2µM−1, and all other
dimensional parameters are defined as in Table 1, we have that the steady state solution of system
(6) is linearly stable. At the points (δz, ρz) ∈ L the system (6) undergoes a Hopf bifurcation, and for
(δz, ρz) ∈ D we have periodic solutions for the BR signalling pathway model.
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Figure 5: Numerical verification of the existence of a Hopf bifurcation. a) at the critical values,
Im(λ2,3) are non-zero. b) derivatives of Re(λ2,3) w.r.t. both δz and ρz (green dots and magenta
crosses respectively). Values pass through zero at the points of the curve in a) where δz or ρz take
their extrema. At such points there is a bifurcation only in one of the parameters, the parameter for
which Re(λ2,3) has non-zero derivative.
5 Spatially Heterogeneous Model for the BR Signalling Pathway
The BR signalling pathway is a process which has distinct functions at different spatial locations in
the cell, Fig. 6. Thus it is important to extend the ODE model (1) and analyse the dependence of the
dynamics of the pathway components on the spatial distribution.
∅ BR
BKI1
BRI1
BZR BZR-p
Nucleus
ER
Figure 6: Diagram of the spatial heterogeneity considered for the model of the BR signalling pathway
(7)-(9). BR (red circles), BKI1 (blue squares) and BZR-p (yellow diamonds with black dots) diffuse
freely in the cytoplasm, where BR is also degraded. At the membrane, both BR and BKI1 are
perceived by BRI1 (black y-shapes) and form complexes with it. In the nucleus (brown) BKI1 activates
dephosphorylation of BZR-p to BZR (yellow diamonds), and inhibits phosphorylation of BZR to BZR-
p. BR is synthesised in the endoplasmic reticulum (ER, grey crescent) which is continuous with the
nuclear membrane.
We consider a spatially heterogeneous model for the BR signalling pathway in the one-dimensional
domain Ωc = (0, lc) representing a part of the plant cell cytoplasm, where lc denotes the length of the
cell segment we consider. The boundaries of Ωc are denoted by Γn modelling the cell nucleus, and Γc
representing the cell membrane, Fig. 7.
We assume the diffusion of BR (b), BKI1 (k) and BZR-p (zp) in the cytoplasm:
∂tb = Db∂
2
xb− µbb
∂tk = Dk∂
2
xk
∂tzp = Dz∂
2
xzp
 in Ωc. (7)
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Γc Γn
Ωc (cytoplasm)
Figure 7: A diagram of the one-dimensional domain in which system (7)-(9) was solved. Ωc = (0, lc)
represents the cytoplasm, Γc the plasma membrane, and Γn the nucleus.
The only reaction that takes place in Ωc is the degradation of BR since we assume that the phos-
phorylation status of BZR is modulated only in the nucleus. The dynamics occurring on the plasma
membrane Γc are the interactions between b, k, and receptor BRI1 (rk, rb). Since we assume that the
receptors are membrane-bound a system of ODEs, similar to the corresponding equations in system
(1), is considered to model the dynamics of rk and rb. The effect of the interactions between b, k, rk,
and rb on the dynamics of b and k is defined by Robin boundary conditions for b and k on Γc. Finally,
we assume that the BZR-p cannot diffuse out of the cell, which we model by a zero-flux boundary
condition on Γc. Thus on Γc we have
−Db∂xb = βkr˜bk − βbr˜kb
−Dk∂xk = βbr˜kb− βkr˜bk
−Dz∂xzp = 0
dr˜k
dt
= βkr˜bk − βbr˜kb
dr˜b
dt
= βbr˜kb− βkr˜bk

on Γc. (8)
In the nucleus Γn we consider both the phosphorylation and dephosphorylation of BZR. Although the
exact subcellular location of BR biosynthesis has not been experimentally demonstrated, the likely
location is the endoplasmic reticulum [46]. The endoplasmic reticulum is continuous with the nuclear
membrane, hence we model the BR biosynthesis as occurring on Γn. We assume that BKI1 cannot
enter the nucleus and consider zero-flux boundary conditions for k on Γn.
Db∂xb =
α˜b
1 + (θ˜bz˜)hb
Dk∂xk = 0
Dz∂xzp = − δ˜zzpk + ρz z˜
1 + (θzk)hz
dz˜
dt
= δzzpk − ρz z˜
1 + (θzk)hz

on Γn. (9)
Since r˜k, r˜b and z˜ are confined to the boundary, they have units of mol/m
2. Thus we have the fol-
lowing scaled relationships between variables r˜k, r˜b and z˜ in (7)-(9) and the corresponding variables
rk, rb and z in (1): r˜k = lcrk, r˜b = lcrb, z˜ = lcz. In order to preserve the balance of units some
parameters from model (1) also had to be rescaled, specifically α˜b = lcαb, δ˜z = lcδz and θ˜b = θb/lc.
We estimated the diffusion constant Db = 60µm
2min−1 by taking the value reported for Progesterone
(a steroidal hormone with a similar structure to BL) in physiological solution from [47]. We also took
Dk = Dz = 0.125 µm
2min−1 for the diffusion constant for proteins from [48]. lc was taken to be 7.43
µm from measurements of root cell sizes from unpublished data. All other parameters were taken to
be the same as in Table 1 or Table 2.
Model (7)-(9) was solved numerically to analyse the changes of the model solutions due to the spatial
heterogeneity of signalling processes. In the fitted parameter regimes, averaged solutions of the model
(7)-(9) have similar behaviour to solutions of (2), Fig. 8, however a distinct spatial distribution of BR
is characteristic for (7)-(9), see Fig. 9. In the oscillatory parameter regime discussed in section 4.1,
the PDE-ODE model (7)-(9) was found to have increased amplitude and period of oscillations, see
Fig. 8. For solutions of model (7)-(9) we also observe oscillatory behaviour for a much wider range of
values of δz and ρz than for model (2).
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Figure 8: Comparison between the dynamics of BR for the ODE model (6), and the PDE-ODE model
(7)-(9) for various parameter values. For comparison, the solutions to the PDE-ODE model have been
averaged over the space, and the initial conditions are such that they are equal for the ODEs and
the averaged PDEs. a) Both models were solved with the fitted parameters (parameters in Tables 1
and 2 correspond to set 1 and set 2 respectively), and show similar behaviour. b) Models were solved
for δz = 1.02 × 10−2, ρz = 1.33 × 10−3, θz = 41.2 and all other parameters as in Tables 1 and 2
respectively. The ODE model tends quickly to steady state, whereas the PDE-ODE model exhibits
damped oscillations. c) Models were solved for δz = ρz = 4, θz = 41.2, and all other parameters as
in Table 1. Both systems exhibit periodic solutions, but the PDE-ODE model has a much reduced
frequency and much increased amplitude as compared to the ODE model. d) δz = 14, ρz = 35,
θz = 41.2, and all other parameters as in Table 1, ODE model has moved outside of the oscillatory
parameter regime, however the same is not true for the PDE-ODE model, which continues to have
oscillatory behaviour for values of δz, ρz in excess of 1000.
6 Derivation of a Mathematical Model for Crosstalk between the
BR and GA Signalling Pathways
Here we consider a mathematical model for the crosstalk between the BR and GA signalling pathways.
BRs and GAs can play similar independent roles in development both having important roles in growth
[15, 54], as well as acting together via shared gene expression, and through interactions between their
signalling pathways [9, 51]. We aim to use our model to analyse the three different mechanisms of
crosstalk between the BR and GA signalling pathways proposed in [31, 53, 56] and to attempt to
establish which mechanism has the most significant influence on the dynamics of the pathways.
6.1 Mathematical Modelling of GA Signalling
A detailed model of the GA signalling pathway was derived and examined in [36], consisting of a
system of 21 ODEs and 42 parameters. It considers both the interaction of the GA4, GID1 and
DELLA, and the GA4 biosynthesis pathway, where GA12 is converted to GA15 is converted to GA24
is converted to GA9, all catalysed by enzyme GA20ox, and GA9 is converted to GA4, catalysed by
GA3ox.
Since a model for crosstalk must include variables for both pathways involved, as well as potentially
introducing new variables specific to their interactions, a system of ODEs describing such a model
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Figure 9: The spatial distribution of BR in the cell segment Ωc, solution of (7)-(9), at different times,
where ‘parameter set 1’ and ‘parameter set 2’ correspond to parameter values in Table 1 and Table 2
respectively. The steady state concentration of BR is greater for solutions with parameter set 1,
Table 1, than for solutions with parameter set 2, Table 2.
may be very large. This being the case, we first reduce the size of the GA signalling model that was
derived in [36]. We reduce the model by assuming that the dynamics of the molecules involved in the
GA biosynthesis pathway are much faster compared to the dynamics of other processes involved in
the signalling pathway that their levels remain at a steady state. This enables us to write a system of
algebraic equations governing GA12, GA15, GA24, GA9, GA20ox and GA3ox, as well as their relevant
mRNAs and complexes which may then be solved such that they may therefore be substituted out
of the main system. These substitutions generate a new term governing the biosynthesis of GA4,
where biosynthesis is directly dependent on DELLA concentration, which is then simplified to a
fourth order Hill function, signifying the 4 steps in the biosynthesis pathway. We also assume that
only one configuration of DELLA.GID1c.GA4 may be formed. Overall this removes 27 parameters
and 13 variables from the system in [36], and introduces a new term for the GA4 biosynthesis with
new parameters αg and ϑg. The interested reader may examine both the reduction process as well
as explicit calculations of αg and ϑg in D. Then for r, r
o
g, r
c
g, rd, rm and dm, the concentrations of
GID1, GID1o.GA4, GID1
c.GA4, DELLA.GID1
c.GA4, GID1 mRNA and DELLA mRNA respectively,
we obtain
dr
dt
= −βgrg + γgrog + αrrm − µrr,
drog
dt
= βgrg − γgrog + λorcg − λcrog,
drcg
dt
= −λorcg + λcrog − βddlrcg + (γd + µd)rd,
drd
dt
= βddlr
c
g − (γd + µd)rd,
drm
dt
= φr
(
dl
dl + ϑr
− rm
)
,
ddm
dt
= φd
(
ϑd
dl + ϑd
− dm
)
,
(10)
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and for dl and g, the concentrations of DELLA and GA4 respectively, we have
ddl
dt
= −βddlrcg + γdrd + αddm,
dg
dt
= φg(ωg − g)− βgrg + γgrog + αg
d4l
d4l + ϑg
− µgg.
(11)
Constant Value Units Constant Value Units
βg 1.35 µM
-1min-1 γg 2.84 min
-1
αr 19.3 µM min
-1 µr 3.51 min
-1
λo 0.0776 min-1 λc 0.0251 min-1
βd 10 µM min
-1 γd 0.133 min
-1
µd 6.92 min
-1 αd 5.28× 10−4 µM min-1
φg 1.061× 10−3 min-1 ωg 154.27 µM
αg 6.40× 10−3 µM min-1 ϑg 4.27× 10−13 µM4
µg 0.291 µM min
-1 φr 0.0457 min
-1
ϑr 5.6× 10−4 µM φd 0.0708 min-1
ϑd 0.01 µM
Table 3: Default parameter values used for the GA signalling model. The values of all parameters
except αg and ϑg were taken directly from [36] from which our reduced model has been derived. The
values for αg and ϑg were calculated using the parameters from [36] and the expressions for αg and
ϑg arising from the model reduction, see D.
All parameter values are taken from those for the full model in [36], Table 3. For all components
present in both the full and the reduced model, the initial conditions are taken to be the same as in
[36]. Both the full and reduced models were solved numerically, and these solutions are plotted in
Fig. 10. The two models show excellent agreement being almost indistinguishable for six terms, and
only minor short-term discrepancies for DELLA.GID1c.GA4 and DELLA. Having thus successfully
reduced the GA signalling pathway model while retaining its core behaviour, we derive a model of the
crosstalk between the BR and GA signalling pathways by coupling models (2) and (10), (11).
6.2 The Crosstalk Model
We consider direct crosstalk between the BR and GA signalling pathways. Besides shared gene ex-
pression, two main mechanisms for BR-GA crosstalk have been suggested: direct interaction at the
level of transcription factors BZR and DELLA [31], and BZR-mediated biosynthesis of GA [56]. Here
we derive a mathematical model to compare the behaviour of the system under the three different
mechanisms of crosstalk (interaction between BZR and DELLA, BZR-mediated biosynthesis of GA,
and a combination of both of them) and to analyse their effects on the BR and GA signalling processes.
The existence of an interaction between BZR and DELLA constituting a crosstalk between the BR
and GA signalling pathways was established in [6, 20, 32]. Further to this, in [31] it was found that the
formation of a complex BZR.DELLA inhibits the transcriptional activities of both BZR and DELLA.
A second mechanism of BR-GA crosstalk has been proposed where BZR also has a direct influence on
the GA4 biosynthesis pathway, Fig. 12. In [53] it was discovered that BR induces the expression of
GA3ox-2, leading to the accumulation of GA1, the most bioactive GA for rice. It was also discovered
that the external application of BR induces GA20ox expression in Arabidopsis [33]. Later it was
shown that BRs both regulate GA20ox expression, and are required for the transcription of GA3ox
[56]. Despite good evidence for the coexistence of these two mechanisms, it is still unclear to what
extent each mechanism operates to effect changes in BR and GA signalling processes [40, 52, 57].
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Figure 10: A comparison between the numerical simulations of the full model for the GA signalling
pathway derived in [36], and the reduced model (10), (11) shows very good agreement.
BZR + DELLA BZR.DELLA
βz
γz
Figure 11: BR-GA crosstalk at the level of transcription factors, where BZR and DELLA form a
complex.
BZR DELLA
GA12
GA15
GA24
GA9
GA4
BZR
BZR
Figure 12: Proposed mechanisms for the influence of BZR on GA biosynthesis. The first model (green)
comes from [33], where BZR influences the expression of GA20ox, in the second model (red) from [56]
BZR affects both GA20ox and GA3ox expression, and in the third model (blue) from [53] BZR affects
only GA3ox expression.
To derive the model for BR-GA crosstalk we coupled model (2) and model (10), (11) by adding new
interaction terms describing the crosstalk mechanisms. Two terms were added, a term corresponding
to the interaction of BZR and DELLA, which required the introduction of a new variable denoting the
concentration of the complex BZR.DELLA, and a term corresponding to the BZR-mediated biosyn-
thesis of GA. By varying the parameters of these new terms, we were then able to analyse the influence
that each mechanism exert over the corresponding signalling processes.
BZR.DELLA complex formation is modelled as a reversible reaction between BZR and DELLA. The
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concentration of BZR.DELLA is denoted by zd, and the parameters βz and γz denote the binding rate
of BZR and DELLA and the dissociation rate of BZR.DELLA, respectively,
dzd
dt
= βzzdl − γzzd. (12)
From this we modify system (2) to take account of the dynamics of BZR.DELLA
db
dt
= βk(Rtot −Ktot + k)k − βb(Ktot − k)b+ αb
1 + (θbz)hb
− µbb,
dk
dt
= βb(Ktot − k)b− βk(Rtot −Ktot + k)k,
dz
dt
= δz(Ztot − z − zd)k − ρz z
1 + (θzk)hz
− βzzdl + γzzd.
(13)
System (11) is modified by taking account of the dynamics of BZR.DELLA, and extending the Hill
function describing GA biosynthesis to include BZR-mediated gene expression. For the crosstalk model
we do not assume that exogenous GA is entering the system, hence the term φg(ωg−g) describing this
process in (11) is removed. BZR is assumed to control gene expression in the same manner as DELLA,
but with relative activity described by φz, where φz is the ratio between the binding thresholds of
DELLA and BZR
ddl
dt
= −βddlrcg + γdrd + αddm − βzzdl + γzzd,
dg
dt
= αg
(dl + φzz)
4
ϑg + (dl + φzz)4
− βgrg + γgrog − µgg.
(14)
The values for the parameters βz, γz governing the direct interaction between DELLA and BZR are
estimates from values for similar complex formation and separation from [36]. We first assumed that
the binding thresholds of BZR and DELLA were equal i.e. φz = 1, and then analysed the influence of
variation in φz on the dynamics of the solutions of (10), (12)-(14).
In order to analyse the relative effects of the different crosstalk mechanisms, we examined the be-
haviour of the model for different values of βz, γz and φz. The model was solved numerically for four
different conditions: no crosstalk (βz, γz, φz = 0), crosstalk via BZR activated GA biosynthesis only
(βz, γz = 0), crosstalk via BZR.DELLA complex formation only (φz = 0), and crosstalk via both
mechanisms, Fig. 13. Only for variables including GA were there any differences when including BZR-
mediated biosynthesis of GA, and for all other variables there was close agreement between the cases
of no crosstalk and crosstalk via biosynthesis only, and close agreement between the cases of crosstalk
via complex formation only and crosstalk via both mechanisms. To examine the influences of both
mechanisms on the BR and GA signalling pathways, the relevant parameters were varied. Variation
in βz and γz led to long-term behaviour changes for the components of the BR signalling pathway,
and short-term changes for the components of the GA signalling pathway, Fig. 14. Variations in φz
had very little effect with differences in behaviour in variables containing GA for the cases φz = 0 and
φz > 0 (results omitted). From this we concluded that direct interaction between BZR and DELLA
is the predominant form of crosstalk between the BR and GA signalling pathways.
In order to examine the effects of mutations in the BR signalling pathway upon BR-GA crosstalk,
changes in parameters δz, ρz and θz are introduced into model (10), (12)-(14), Fig. 15. Damped
oscillations in the dynamics of the components of the BR signalling pathway induced no such behaviour
in the dynamics of the GA signalling pathway, and despite causing some changes in the early behaviour
of the dynamics of the GA signalling pathway their long term behaviour remains similar. Alongside
the induced perturbation in the BR signalling pathway, we also varied βz and γz to examine how
crosstalk affects the dynamics of both pathways in this case. We found in the case that βz/γz is large,
the dynamics of the BR signalling pathway are virtually unchanged from the cases with smaller values
of βz/γz, however the long-term behaviour of the GA signalling pathway was significantly effected,
with all components except GA4 and DELLAm having substantially different stationary solutions.
Given the observed large effect of crosstalk on the BR pathway as compared with the GA pathway, see
Figs 13 and 14, we analysed how directly altering each pathway would affect the other, Fig. 16. We
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Figure 13: Comparisons between solutions of the crosstalk model (10), (12)-(14); ‘no crosstalk ’ refers to
the case where βz = γz = φz = 0; ‘biosynthesis’ refers to the case where the only crosstalk between the
BR and GA signalling pathways is BZR-induced biosynthesis of GA (βz = γz = 0, φz 6= 0); ‘complex ’
refers to the case where the only crosstalk between the BR and GA signalling pathways is complex
formation of BZR and DELLA (βz, γz 6= 0, φz = 0); ‘full ’ refers to the case where crosstalk between
the BR and GA signalling pathways can be via both mechanisms BZR-mediated GA biosynthesis and
complex formation of BZR and DELLA (βz, γz, φz 6= 0).
Figure 14: Variation of the values of βz and γz suggests that the BR signalling pathway is more
sensitive to the effects of crosstalk than the GA signalling pathway; ‘no crosstalk ’ corresponds to the
case βz = γz = 0, ‘small ’ the case where βz/γz has order of magnitude zero, i.e. βz/γz ≈ 0.75 ,
for ‘standard ’ βz/γz has order of magnitude two, i.e. βz/γz ≈ 75, and for ‘large’ βz/γz has order of
magnitude four, i.e. βz/γz ≈ 7500.
modelled the overexpression of BR and GA hormones by increasing parameters αb and αg. Overex-
pression of BR (increase of αb) resulted in major changes in the BR signalling pathway with increases
in the concentrations of BR, BKI1 and BZR, but almost negligible change in the GA signalling path-
way. Overexpression of GA had more widespread effects, causing increases in the concentrations of
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Figure 15: Oscillations in the BR pathway lead to short term changes in the dynamics of the GA
pathway, and increasing βz/γz causes more long term effects on the GA signalling pathway. In the
‘standard ’ case all parameters are as in Tables 1 and 3 and βz = 10 µM
−1min−1, γz = 0.133 min−1.
For the ‘BR perturbed ’ case parameters δz and ρz have had their orders of magnitude increased by
three, θz = 41.2µM
−1, and all other parameters are as in Tables 1 and 3 and βz = 10, γz = 0.133.
The ‘BR perturbed, βz/γz large’ has the same parameter values as the ‘BR perturbed ’, however here
βz/γz has order of magnitude four, i.e. βz/γz ≈ 7500, similar to Fig. 14.
BZR, GID1o.GA4, GID1
c.GA4, DELLA.GID1
c.GA4 and GA4, and decreases in the concentrations of
BR, BKI1, GID1o, GID1m and DELLA.BZR.
In all cases of BR-GA interactions discussed here we considered the parameter values for the BR
signalling pathway model as in Table 1. However similar behaviours are observed also if considering
the parameter values as in Table 2, hence we do not present the simulation results for those cases.
6.3 Modelling Spatial Heterogeneity in the Crosstalk Signalling
We also considered the spatial heterogeneity in the crosstalk model. Here, the coupled PDE-ODE
model for the BR signalling pathway (7)-(9) was modified to include the components of the GA
signalling pathway. GA was assumed to be able to diffuse freely throughout the cell, and all other
components of the GA signalling pathway were assumed to be nuclear-localized. We retain the same
assumptions for the components of the BR signalling pathway as in section 5. This led to a set of
reaction-diffusion equations for BR, BKI1, BZR-p the same as in (7), and for GA:
∂tg = Dg∂
2
xg − µgg in Ωc. (15)
We assume that receptor based interactions of BR, BKI1 and BRI1 remain the same as in (8), and
no influx of exogenous GA on the plasma membrane:
−Dg∂xg = 0 on Γc. (16)
The production of BR, change in phosphorylation status of BZR, and interactions between BZR and
DELLA occur in the plant cell nucleus and are modelled as flux boundary conditions and ODEs on
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Figure 16: Examining the effects of hormonal overexpression on the dynamics of solutions of model
(10), (12)-(14) for the crosstalk between the BR and GA signalling pathways. For the ‘standard ’ case
all parameters are as in Tables 1 and 3 and βz = 10 µM
−1min−1, γz = 0.133 min−1; in the ‘BR
overexpression’ case, αb’s order of magnitude is increased by one; in the ‘GA overexpression’ case αg’s
order of magnitude is increased by one.
the boundary Γn:
Db∂xb =
α˜b
1 + (θ˜bz)hb
Dk∂xk = 0
dz˜
dt
= δ˜zzpk − ρz z˜
1 + (θzk)hz
− β˜z z˜d˜l + γz z˜d
Dz∂xzp = − δ˜zzpk + ρz z˜
1 + (θzk)hz

on Γn. (17)
All processes of the GA signalling pathway apart from degradation of GA are localised to the nucleus
and are modelled by a system of ODEs for GID1o, GA4.GID1
o, GA4.GID1
c, DELLA.GA4.GID1
c,
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DELLA, GID1m and DELLAm, and a flux boundary condition for GA on the boundary Γn:
dr˜
dt
= − βg r˜g + γg r˜og + α˜rrm − µrr
dr˜og
dt
= βg r˜g − (γg + λc)r˜og + λor˜cg
dr˜cg
dt
= λcr˜og − λor˜cg − β˜dd˜lr˜cg + (γd + µd)r˜d
dr˜d
dt
= β˜dd˜lr˜
c
g − (γd + µd)r˜d
dd˜l
dt
= − β˜dd˜lr˜cg + γdr˜d + α˜ddm − β˜z z˜d˜l + γz z˜d
Dg∂xg = αg
(d˜l + φz z˜)
4
ϑ˜g + (d˜l + φz z˜)4
− βg r˜g + γg r˜og
drm
dt
= φr
(
d˜l
θ˜r + d˜l
− rm
)
ddm
dt
= φd
(
θ˜d
θ˜d + d˜l
− dm
)

on Γn. (18)
Finally crosstalk is modelled via formation of the BZR.DELLA complex
dzd
dt
= βzzdl − γzzd on Γn. (19)
Similar to model (7)-(9), to ensure appropriate units we obtain rescaled relations between boundary-
localised variables in model (15)-(19) and the corresponding variables in model (10), (12)-(14), i.e.
r˜k = lcrk, r˜b = lcrb, z˜ = lcz, r˜ = lcr, r˜
o
g = lcr
o
g, r˜
c
g = lcr
c
g, r˜d = lcrd, d˜l = lcdl, and z˜d = lczd. Since
rm and dm were already relative quantities with no units there was no need for them to be scaled. To
balance units certain parameters also had to be rescaled: parameters αb, δz, αr, αd, αg, ϑr and ϑd
from (10), (12)-(14) were all multiplied by lc such that α˜b = lcαb etc.; θb, βz and βd were all divided by
lc such that θ˜b = θb/lc etc.; and ϑg was scaled such that ϑ˜g = l
4
cϑg. Since GA molecules have similar
size to BR molecules, we consider Dg = Db. All other parameters were taken to be the same as those
used for model (10), (12)-(14), i.e. from Tables 1 and 3 and βz = 10 µM
−1min−1, γz = 0.133 min−1.
System (7), (8), (15)-(19) was solved numerically, and these solutions were averaged over the space
and then compared to the solutions of system (10), (12)-(14). The behaviour of the two models was
similar for most of the parameter sets considered in section 6.2, see e.g. standard cases in Figs. 15
and 17, however spatially heterogeneous steady states are characteristic for model (7), (8), (15)-(19),
see Fig. 18. Spatial heterogeneity does have a significant effect in the case where perturbations in the
phosphorylation of BZR lead to damped oscillations in the BR signalling pathway, with much different
behaviours of solutions of system (7), (8), (15)-(19) than for (10), (12)-(14), comparing Figs. 15 and
17. When the BR signalling pathway is ‘strongly perturbed’, i.e. δz and ρz are increased sufficiently
high, the oscillations in the components of the BR signalling pathway also cause oscillatory behaviour
in the components of the GA signalling pathway, suggesting that spatial heterogeneity may contribute
to instability of solutions in extreme cases.
7 Discussion and Conclusion
Plants rely on complex integrated hormonal signalling pathways in order to respond and adapt to
changing environmental conditions. The BR and GA signalling pathways have a diverse range of effects
on plant growth and developmental processes, some of which overlap. To examine the behaviours
of these signalling pathways and their interactions we developed mathematical models of the BR
signalling pathway, and crosstalk between the BR and GA pathways under assumptions of both
spatial homogeneity: models (1) and (10), (12)-(14), and spatial heterogeneity of signalling processes:
models (7)-(9) and (7), (8), (15)-(19).
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Figure 17: Solutions of system (7), (8), (15)-(19), averaged over space. For ‘standard ’ parameter values
are as in Tables 1 and 3 and βz = 10 µM
−1min−1, γz = 0.133 min−1. For both ‘BR perturbed ’ and ‘BR
perturbed, βz/γz large’ δz and ρz have had their orders of magnitude increased by two, θz = 41.2µM
−1,
βz/γz has order of magnitude four, i.e. βz/γz ≈ 7500, for ‘BR perturbed, βz/γz large’ only, and all
other parameters are as in Tables 1 and 3. For the case ‘BR strongly perturbed ’ δz and ρz have had
their orders of magnitude increased by three, θz = 41.2µM
−1, all other parameters as in Tables 1 and
3 and βz = 10 µM
−1min−1, γz = 0.133 min−1.
Figure 18: The spatial distribution of BR and GA in the cell segment Ωc (solutions of (7), (8),
(15)-(19)) at different times, parameter values are as in Tables 1 and 3 and βz = 10 µM
−1min−1,
γz = 0.133 min
−1. The concentration of BR starts of uniform, and is produced at x = 7.43 µm, the
nucleus, leading to the greatest concentration at this point. The overall concentration increases over
the first 8 h, but then decreases steadily, arriving at a spatially heterogeneous steady state after 120
h. The concentration of GA is also greater at x = 7.43 µm where it is produced, but GA attains its
spatially heterogenous steady state after 24 h, much more quickly than BR.
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The parameters in the model for the BR signalling pathway (2) were determined upon validating the
model by comparing its numerical solutions to experimental data from [50]. Using numerical optimi-
sation techniques we were able to get a good fit for the diverse data sets corresponding to the different
growth conditions considered in [50]. Our calculations resulted in values for δz and ρz of a much lower
order of magnitude than the rest of the parameters in the model, suggesting that the phosphorylation
of BZR occurs on a much slower time scale than e.g. perception of BR by BRI1. The model param-
eters were optimised under two different constraints on the value of βk, (4) and (5), corresponding
to two different mechanism governing the interactions of BR, BRI1, and BKI1, where BR and BKI1
binding to and dissociation from BRI1 is instantaneous, or a complex BR.BRI1.BKI1 can be formed,
respectively. Most parameters had very similar or identical values, with the only notable differences
being for (naturally) βk, and the parameters governing the phosphorylation of BZR: δz, ρz. Overall
our model fitted the data well for both mechanisms (4) and (5), with R2 values of 0.89 and 0.92
respectively, suggesting that both of these mechanisms may accurately predict the dynamics of the
BR signalling pathway. The only growth condition for which the model had a less accurate fit was for
when the growth medium was supplemented with BL.
Qualitative analysis of system (6) revealed that it has only one steady state for the parameter space
P , and that this steady state is stable in a neighbourhood of the parameter sets defined in Tables 1
and 2. Bifurcation analysis showed that for a bounded set of values of (δz, ρz), with θz = 41.2 µM
−1
and all other parameters as in Table 1, system (6) has periodic solutions, i.e. system (6) undergoes
a Hopf bifurcation upon varying parameters δz, ρz, corresponding to the dephosphorylation rate and
phosphorylation rate of BZR respectively. No such bifurcations were found when considering a large
range of values for δz, ρz , and θz = 41.2 µM
−1 and all other parameters as in Table 2. However, since
the values of δz, ρz for which a bifurcation exists are likely to be biologically unrealistic as they are
much greater than the values yielded by validation of the model by experimental data, this suggests
that within some range of normal function the BR signalling pathway has good stability, which is
of crucial importance for proper function of plant tissues. Results also suggest that if BR and BKI1
associate and dissociate from BRI1 instantaneously, as in mechanism (4), stability of the pathway
is principally dependent upon the phosphorylation state of BZR. Further if BR.BRI1.BKI1 can be
formed, as in mechanism (5), stability of solutions to model (6) for a wide range of all parameters
ensures effective BR homeostasis.
Numerical solutions for the spatially heterogeneous model (7)-(9) averaged over space and ODE model
(2) for the BR signalling pathway demonstrated similar behaviours for the parameter sets when the
solutions of (7)-(9) and of (2) converge to the steady state as t → ∞. In the oscillatory parameter
regime discussed in section 4.1, the PDE-ODE model exhibited distinct behaviour to the ODE model,
Fig. 8, suggesting that under such conditions the spatial heterogeneity of the signalling pathway has
a large influence on the dynamics of the molecules involved in the BR signalling pathway.
We investigated the effects of interactions between the BR and GA signalling pathways and the
BR-GA signalling crosstalk mechanisms[31, 53, 56] by coupling (2), (10) and (11) to obtain model
(10), (12)-(14), in order to establish which mechanism is more biologically significant [40, 52, 57]. We
examined the effects of BZR-mediated biosynthesis of GA and of BZR.DELLA complex formation
on the behaviour of the BR and GA signalling pathways. We modelled the cases where there was:
no crosstalk, BZR-mediated biosynthesis of GA only, BZR.DELLA complex formation only, and both
BZR-mediated biosynthesis of GA and BZR.DELLA complex formation. The cases of no crosstalk and
BZR-mediated biosynthesis exhibited similar behaviour to each other, and the cases of BZR.DELLA
complex formation and both BZR-mediated biosynthesis of GA and BZR.DELLA complex forma-
tion exhibited similar behaviour to each other, Fig. 13. Further, upon variation of the ratio between
DELLA and BZR binding thresholds φz the change in behaviour of most components of both path-
ways was negligible, whereas the variations in BZR.DELLA binding βz and dissociation γz rates had
a strong effect upon the BR signalling pathway, Fig. 14. From this we concluded that BZR.DELLA
complex formation has a greater effect on the behaviour of the BR and GA signalling pathways. This
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suggests that interactions between BZR and DELLA exert more influence over the dynamics of the
pathways than BZR-mediated biosynthesis of GA and are more likely to be able to promote any
effective change in the behaviour of the signalling processes. Numerical results also demonstrated
that for all parameter sets where solutions tended to a steady state, the solutions of model (10),
(12)-(14) and the averaged over space solutions of model (7), (8), (15)-(19) exhibit similar dynam-
ics, although spatially heterogenous steady-states are obtained for BR and GA concentrations, Fig. 18.
To examine whether disturbance of one signalling pathway had a greater effect on the other, we
modelled the effects of overexpression of both BR and GA. Overexpression of BR resulted in large
changes in the dynamics of the components of the BR signalling pathway only, and overexpression of
GA resulted in large changes in the dynamics of the components of the GA signalling pathway, and
small changes in the dynamics of the components of the BR signalling pathway, Fig. 16. In addition
variation of βz and γz led to large changes in the dynamics of the BR pathway but only short term
changes in the dynamics of the GA pathway. From this we concluded that in general perturbations
in the GA signalling pathway have greater influence on the BR signalling pathway than vice versa.
To examine the effects of mutations in the BR signalling pathway on the GA pathway, models (10),
(12)-(14) and (7), (8), (15)-(19) were solved numerically considering different values for the parameters
δz and ρz governing BZR phosphorylation. For the components of the GA signalling pathway solutions
to the ODE model showed different short-term behaviour but tended to the same steady state, whereas
the components of the BR signalling pathway tended to different steady state. If varying βz and γz
such that βz/γz was large in the case when we have damped oscillation in the components of the BR
signalling pathway, the dynamics of some of the components of the GA signalling pathway were sig-
nificantly altered but the dynamics of the components of the BR signalling pathway were unchanged,
Fig. 15. For the spatially heterogeneous model (7), (8), (15)-(19), in the oscillatory parameter regime
oscillations in the BR signalling pathway propagated into the GA signalling pathway, Fig. 17. From
this we conclude that only in the case where there is disturbance in both the BR signalling path-
way and the mechanism of crosstalk between the BR and GA signalling pathways the dynamics of
molecules in the BR signalling pathway have greater influence on the dynamics of molecules in the
GA signalling pathway. This, together with the results discussed in the previous paragraph, suggests
that under normal crosstalk the stability of individual signalling pathways is maintained even if there
are disturbances in the other pathway.
To conclude, our analysis of new mathematical models for BR signalling pathway and the crosstalk
between the BR and GA signalling pathways, derived here, provide a better understanding of the dy-
namics of signalling processes, dependent on model parameters and spatial heterogeneity. Our results
for the BR signalling pathway highlight its stability, and suggest that this stability is particularly de-
pendent on the mechanisms governing the phosphorylation state of BZR and the subcellular locations
of these processes. Our results suggest that direct interaction between BZR and DELLA exerts a
larger influence on the dynamics of the BR and GA signalling pathways than BZR-mediated biosyn-
thesis of GA, and hence may be the primary mechanism of crosstalk between the two pathways. Our
analysis indicates that during normal plant function, the GA signalling pathway exerts more influence
over the BR signalling pathway than BR on GA, but mutations in the BR signalling pathway cause
BR signalling to exert some short time influence over GA pathway and greater influence when coupled
with disturbances in the crosstalk mechanism. Both BR signalling and crosstalk between BR and GA
signalling are important for plant growth and development. Our modelling and analysis results also
can be used to model the interactions between growth and signalling processes in order to better un-
derstand the influence of the BR and GA signalling pathways on growth and developmental processes
in plants.
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A Validation of model (2) against experimental data
To improve the optimisation process for parameter estimation we calculated additional constraints for
some parameter values using experimental data.
We first calculated the level of endogenous BL using a value of 5.26 ng g-1 (the midpoint of the
reported range in mature plants) which was obtained from [62]. In order to convert this into an ap-
propriate value in units of µM, we first need the density of plant material. We estimate this by noting
that the density of cellulose is 1.5 kg L-1 [21], and that cellulose constitutes approximately 50% of
plant material [39]. For the outstanding amount, we make an assumption that rest of the material is
largely accounted for by cytoplasm, which we assume to have an approximately equal density to water,
i.e. 1 kg L-1. From this we get an estimate of 1.25 kg L-1 for the density of plant material. Finally
the molecular weight of BL is 480.686 g mol-1 [18]. From this data we calculate the endogenous BR
concentration as
quantity × density
molecular weight
=
(5.26× 10−6g kg−1)× (1.25 kg L−1)
480.686 g mol−1
= 0.0137× 10−6mol L−1 = 13.7× 10−3 µM.
We denote this new constant by [BR]0, and assume it to be the steady state concentration of BR.
We write µb in terms of αb, θb, δz, Ztot, ρz, θz and hz by considering the steady state solution of (2):
µb =
αb
[BR]0
(
1 +
(
θb
Ztotδz [BKI1]0(1+(θz [BKI1]0)hz )
ρz+δz [BKI1]0(1+(θz [BKI1]0)hz )
)hb) ,
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where [BKI1]0 denotes the steady state concentration of BKI1, which can be calculated using [BR]0.
We adopt two approaches for the calculation of [BKI1]0 and βk. First we consider the BR.BRI1
dissociation constant, its value to be dependent on the steady state concentrations of BR, BRI1.BKI1,
and BR.BRI1 such that
Kd =
r∗kb
∗
r∗b
, (20)
where Kd denotes the BR.BRI1 dissociation constant, and r
∗
k, b
∗, and r∗b denote the steady state
concentrations of BRI1.BKI1, BR, and BR.BRI1 respectively. Taking b∗ = [BR]0, and rewriting r∗k,
r∗b in terms of k
∗, the steady state concentration of BKI1, (20) may be rewritten as
Kd(Rtot −Ktot + k∗) = (Ktot − k∗)[BR]0. (21)
Thus we may solve for k∗ to obtain an expression for [BKI1]0:
[BKI1]0 =
Ktot[BR]0 −Kd(Rtot −Ktot)
Kd + [BR]0
, (22)
and by taking Kd = 11.2 nM, the midpoint of values reported in [64], calculate that [BKI1]0 =
34.1 × 10−3 µM. Using this value for [BKI1]0 in conjunction with the steady state solution of the
second equation in (2), we write
βk =
(Ktot − [BKI1]0)[BR]0
(Rtot −Ktot + [BKI1]0)[BKI1]0βb
= 0.329βb,
giving us an expression for βk in terms of βb.
For the second method of calculating [BKI1]0 and βk, we considered that BRI1 has a state where
both BR and BKI1 are bound to it, i.e. the full receptor-based dynamics would look like
db
dt
= −β1brk + γ1rbk
dk
dt
= −β2krb + γ2rbk
drk
dt
= −β1brk + γ1rbk
drb
dt
= −β2krb + γ2rbk
drbk
dt
= β1brk + β2krb − γ1rbk − γ2rbk
(23)
where the variable rbk denotes the concentration of BR.BRI1.BKI1, and β1 and β2 (γ1 and γ2) represent
the association (dissociation) rates of BR and BRI1.BKI1, and BKI1 and BR.BRI1 (BR.BRI1.BKI1)
respectively. Thus the dissociation constant of BR and BRI1.BKI1, and the dissociation constant of
BKI1 and BR.BRI1, denoted Kd and Km respectively, may be defined by
Kd =
γ1
β1
, Km =
γ2
β2
.
Assuming rbk to be constant allows us to rewrite (23) as
db
dt
= − γ2β1
γ1 + γ2
brk +
γ1β2
γ1 + γ2
krb,
dk
dt
= − γ1β2
γ1 + γ2
krb +
γ2β1
γ1 + γ2
brk,
drk
dt
= − γ2β1
γ1 + γ2
brk +
γ1β2
γ1 + γ2
krb,
drb
dt
= − γ1β2
γ1 + γ2
krb +
γ2β1
γ1 + γ2
brk,
(24)
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which means that we may not only define βk and βb as
βk =
γ1β2
γ1 + γ2
, βb =
γ2β1
γ1 + γ2
, (25)
but that we may further divide βk through by βb to show that
Kd
Km
=
βk
βb
,
and hence
βk =
Kd
Km
βb.
A value of Km = 4.28µM was reported in [61], giving an expression βk =
(
2.62× 10−3)βb. The steady
state solution of the second equation in (2) may thus be written as
(k∗)2 +
(
(Rtot −Ktot) + Km
Kd
[BR]0
)
k∗ − Km
Kd
Ktot[BR]0 = 0, (26)
which may be solved for k∗, and hence an expression for [BKI1]0 is found
0 =
1
2
√(
(Rtot −Ktot) + Km
Kd
[BR]0
)2
+ 4
Km
Kd
Ktot[BR]0
− 1
2
(
(Rtot −Ktot) + Km
Kd
[BR]0
)
,
giving [BKI1]0 = 61.3× 10−3 µM.
In order to check whether a more accurate estimation of the parameters was given by fitting a non-
dimensional model which does not scale time by one of the fitting variables:
db¯
dt¯
= β¯k(κ− 1 + k¯)k¯ − β¯b(1− k¯)b¯+ µ¯b
(
1
1 + (θ¯bz¯)hb
− b¯
)
,

dk¯
dt¯
= β¯b(1− k¯)b¯− β¯k(κ− 1 + k¯)k¯,
dz¯
dt¯
= δ¯z(1− z¯)k¯ − ρ¯z z¯
1 + (θ¯z z¯)hz
,
(27)
where
β¯b = 60βbKtot, β¯k = 60
βk(Ktot)
2µb
αb
, κ = RtotKtot ,
µ¯b = 60µb, θ¯b = θbZtot,  =
Ktotµb
αb
,
δ¯z = 60δzKtot, ρ¯z = 60ρz, θ¯z = θzKtot,
(27) was also fitted to the experimental data. The parameters whose dimensional values could be
found had close agreement with those found fitting model (2), Tables 4 and 5, and so it is better to
consider the fitting of the dimensional model (2) to the experimental data.
B Linearised Stability Analysis for the Model (6) of the BR Sig-
nalling Pathway
B.1 Proof of positive invariance of M = [0, 1 + βkκ]× [0, 1]× [0, 1].
To prove that M is positive invariant, we first consider M1 := {(b, k, z) ∈ R3 | b, k, z ≥ 0} and show
the non-negativity of solutions of (6). Restricting b = 0, we obtain that f · (1, 0, 0) = βk(κ − 1 +
k)k + 1
1+(θbz)
hb
, and similarly that f · (0, 1, 0) = βb b restricting k = 0, and f · (0, 0, 1) = δzk restricting
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Constant Value Units Constant Value Units
βb 8.33 µM
-1 min-1 βk 2.73 µM
-1 min-1
αb 0.27 µM min
-1 µb 3.58 min
-1
δz 9.97× 10−4 µM-1min-1 ρz 1.30× 10−4 min-1
θz 4.05 µM
-1 hz 6
Table 4: Transformed parameters when fitting the non-dimensionalised model (27) against experi-
mental data from [50], and using (3) and (4). Due to the nature of the non-dimensionalisation, the
dimensional parameters θb and Ztot cannot be found.
Constant Value Units Constant Value Units
βb 8.06 µM
-1 min-1 βk 2.11× 10−2 µM-1 min-1
αb 0.27 µM min
-1 µb 3.68 min
-1
δz 1.77× 10−3 µM-1min-1 ρz 4.33× 10−4 min-1
θz 3.98 µM
-1 hz 6
Table 5: Transformed parameters when fitting the non-dimensionalised model (27) against experi-
mental data from [50], and using (3) and (5). Due to the nature of the non-dimensionalisation, the
dimensional parameters θb and Ztot cannot be found.
WT1 BRZ1 WT2 BL2 MUT3 BRZ3 MUT4 BL4
βb 8.33 8.49 8.50 8.42 2.36× 10−3 2.46× 10−3 2.43× 10−3 2.31× 10−3
βk 2.73 2.72 2.72 2.80 3.26×10−12 3.10×10−12 2.95×10−12 3.09×10−12
αb 0.27 6.29×10−2 6.29×10−2 6.08×10−2 0.27 0.27 0.28 0.27
θb 1.96 2.01 2.01 2.11 1.96 1.96 1.92 1.88
µb 3.58 3.54 3.54 13.98 3.50 3.40 3.40 3.57
δz 1.02×10−3 1.05×10−3 1.07×10−3 1.10×10−3 1.02×10−3 1.01×10−3 1.01×10−3 1.06×10−3
Ztot 2.65 2.72 2.72 2.75 2.65 2.58 2.58 2.58
ρz 1.33×10−4 1.39×10−4 1.32×10−4 1.32×10−4 1.34×10−4 1.33×10−4 1.29×10−4 1.22×10−4
θz 3.95 4.10 4.30 4.06 3.76 3.93 3.91 3.91
hz 6.02 5.82 5.52 5.65 5.95 5.75 5.76 5.76
Table 6: Fitted model parameters obtained by fitting model (2) under conditions (4),(3) to experimen-
tal data for each growth condition. Here WT1 corresponds to the case where wild-type plants were
grown under control conditions, BZR1 to the case where wild-type plants were grown in a medium
containing BRZ, WT2 to the case where wild-type plants had been grown in a medium containing
BRZ 5µM for two days, BL2 to the case where wild-type plants had been grown in a medium contain-
ing BRZ 5µM for two days and then supplemented with 0.1µM BL, MUT3 corresponds to the case
where mutant plants were grown under control conditions, BZR4 to the case where mutant plants
were grown in a medium containing BRZ, MUT4 to the case where mutant plants had been grown in
a medium containing BRZ 5µM for two days, BL4 to the case where mutant plants had been grown
in a medium containing BRZ 5µM for two days and then supplemented with 0.1µM BL.
z = 0. Since b, k, z ≥ 0 we also obtain that f(u) · n(u) ≥ 0 ∀u ∈ ∂M1 and any flow that starts in
M1 must remain in M1 for all t, and hence M1 is a positive invariant set. To show boundedness of
solutions of (6), consider M2 := {(b, k, z) ∈ R3 | b ≤ 1 + βkκ, k ≤ 1, z ≤ 1}. Restricting b = 1 + βkκ,
we obtain that f · (−1, 0, 0) = (βb(1 − k) + 1)(1 + βkκ) − βk(κ − 1 + k)k − 11+(θbz)hb , and similarly
that f · (0,−1, 0) = βk κ restricting k = 1, and f · (0, 0,−1) = ρz1+(θzk)hz restricting z = 1. Note that
f · (−1, 0, 0) has no critical points for 0 ≤ k ≤ 1, and has value βb(1 + βkκ) for k = 0, and 0 for k = 1.
Thus f(u) · n(u) ≥ 0 ∀(u) ∈ ∂M2 and any flow that starts in M2 must remain in M2 for all t, hence
M2 is a positive invariant set. Thus M := M1 ∩M2 is a positive invariant region [5].
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B.2 Calculations for the proof of Theorem 2
Any steady state (b∗, k∗, z∗) of (6) satisfies
0 =
1
1 + (θbz∗)hb
− b∗,
0 = βb(1− k∗)b∗ − βk(κ− 1 + k∗)k∗,
0 = −ρz z
∗
1 + (θzk∗)hz
+ δz(1− z∗)k∗.
Using simple algebraic manipulation on the system above, we find b∗ and z∗ in terms of k∗
b∗ =
1
1 +
(
θb
δzk
∗ (1 + (θzk∗)hz)
ρz + δzk∗ (1 + (θzk∗)hz)
)hb = βk (κ− 1 + k∗) k∗βb (1− k∗) ,
z∗ =
δzk
∗ (1 + (θzk∗)hz)
ρz + δzk∗ (1 + (θzk∗)hz)
.
Then k∗ is defined as a root of the following non-linear function
g(k∗) : = βk (κ− 1 + k∗) k∗
1 +( θbδzk∗ (1 + (θzk∗)hz)
ρz + δzk∗ (1 + (θzk∗)hz)
)hb
− βb (1− k∗) .
The derivative of g
dg
dk∗
= βb + βk(κ− 1 + 2k∗)
1 +(θb δzk∗ (1 + (θzk∗)hz)
ρz + δzk∗ (1 + (θzk∗)hz)
)hb
+ βk(κ− 1 + k∗)k∗×
×
hbθbδzρz (1 + (1 + hz)(θzk∗)hz)
(ρz + δzk∗(1 + (θzk∗)hz))
2
(
θbδzk
∗ (1 + (θzk∗)hz)
ρz + δzk∗ (1 + (θzk∗)hz)
)hb−1
which is positive for all p ∈ P and k∗ ∈ [0, 1].
B.3 Characteristic Equation
The Jacobian for system (6) evaluated at the steady state (b∗, k∗, z∗) is given by
−βb(1− k∗)− 1 βk(κ− 1 + 2k∗) + βbb∗ −hbθb(θbz
∗)hb−1
(1+(θbz∗)hb)
2
βb(1−k∗)
 −βbb
∗
 − βk(κ−1+2k
∗)
 0
0 δz(1− z∗) + ρzhzθzz
∗(θzk∗)hz−1
(1+(θzk∗)hz )2
−δzk∗ − ρz1+(θzk∗)hz
 (28)
The coefficients of the characteristic equation associated to Jacobian J (28) are defined as follows
a2 = βb(1− k∗) + 1 + βb

b∗ +
βb

(κ− 1 + 2k∗) + δzk∗ + ρz
1 + (θzk∗)hz
,
a1 =
1

(βbb
∗ + βk(κ− 1 + 2k∗))
(
βb(1− k∗) + 2 + δzk∗ + ρz
1 + (θzk∗)hz
)
+ (βb(1− k∗) + 1)
(
δzk
∗ +
ρz
1 + (θzk∗)hz
)
,
a0 =
1

βb(1− k∗) θbhb(θbz
∗)hb−1
(1 + (θbz∗)hb)2
(
δz(1− z∗) + ρzz
∗θzhz(θzk∗)hz−1
(1 + (θzk∗)hz)2
)
+
1

(βbb
∗ + βk(κ− 1 + 2k∗))
(
δzk
∗ +
ρz
1 + (θzk∗)hz
)
,
where (b∗, k∗, z∗) is a steady state of the system (6).
35
C Non-dimensionalisation of Model (7)-(9) of the BR Signallng
Pathway
Since in the PDE-ODE model (7)-(9) some of the variables are defined on the boundaries we must
consider them in units of mol/m2 instead of mol/m3, compared to the ODE model (2). To adapt the
units, we scale by the length of the cell segment, i.e. r˜k = lcrk, r˜k = lcrk and z˜ = lcz. To preserve the
balance of units in the system, we must scale the following parameters α˜b = lcαb, θ˜b = θb/lc, δ˜z = lcδz.
Applying this scaling and non-dimensionalising via t = t∗t¯, x = lcy, b = b∗b¯, k = k∗k¯, r˜k = r∗kr¯k,
r˜b = r
∗
b r¯b, z˜ = z
∗z¯, zp = z∗p z¯p, system (7)-(9) is transformed to
∂t¯b¯ =
Dbt
∗
(x∗)2
∂2y b¯− µbt∗b¯
∂t¯k¯ =
Dkt
∗
(x∗)2
∂2y k¯
∂t¯z¯p =
Dzt
∗
(x∗)2
∂2y z¯p

in Ω¯c, (29)
−Dbt
∗
(x∗)2
∂y b¯ =
βkt
∗r∗bk
∗
x∗b∗
r¯bk¯ − βbt
∗r∗k
x∗
b¯r¯k
−Dkt
∗
(x∗)2
∂yk¯ =
βbt
∗r∗kb
∗
x∗k∗
b¯r¯k − βkt
∗r∗b
x∗
r¯bk¯
dr¯k
dt¯
= βkk
∗t∗r¯bk¯ − βbb∗t∗b¯r¯k
dr¯b
dt¯
= βbb
∗t∗b¯r¯k − βkk∗t∗r¯bk¯
−Dzt
∗
(x∗)2
∂y z¯p = 0

on Γ¯c, (30)
Dbt
∗
(x∗)2
∂y b¯ =
lcαbt
∗
x∗b∗(1 + ( θbz
∗z¯
lc
)hb)
Dkt
∗
(x∗)2
∂yk¯ = 0
dz¯
dt¯
=
lcδzt
∗p∗k∗
z∗
z¯pk¯ − ρzt∗ z¯
1 + (θzk∗k¯)hz
Dzt
∗
(x∗)2
∂y z¯p = − lcδzt
∗k∗
x∗
z¯pk¯ +
ρzt
∗z∗
x∗p∗
z¯
1 + (θzk∗k¯)hz

on Γ¯n. (31)
Take t∗ = 1/µb, x∗ = lc, b∗ = αb/µb, k∗ = Ktot, r∗k = lcRtot, r
∗
b = lcRtot, z
∗ = lcZtot and p∗ = Ztot.
Then
∂t¯b¯ = D¯b∂
2
y b¯− b¯
∂t¯k¯ = D¯k∂
2
y k¯
∂t¯z¯p = D¯z∂
2
y z¯p
 in Ω¯c. (32)
−D¯b∂y b¯ = β¯kr¯bk¯ − β¯bb¯r¯k
−D¯k∂yk¯ = 1
(
β¯br¯k b¯− β¯kr¯bk¯
)
dr¯k
dt¯
= 2
(
β¯kr¯bk¯ − β¯bb¯r¯k
)
dr¯b
dt¯
= 2
(
β¯bb¯r¯k − β¯kk∗t∗r¯bk¯
)
−D¯z∂y z¯p = 0

on Γ¯c, (33)
36
D¯b∂y b¯ =
1
1 + (θ¯bz¯)hb
D¯k∂yk¯ = 0
dz¯
dt¯
= δ¯z z¯pk¯ − ρ¯z z¯
1 + (θ¯zk¯)hz
D¯z∂y z¯p = − δ¯z z¯pk¯ + ρ¯z z¯
1 + (θ¯zk¯)hz

on Γ¯n, (34)
where
D¯b =
Db
µbl2c
, D¯k =
Dk
µbl2c
, D¯z =
Dz
µbl2c
, β¯k =
βkRtotKtot
αb
,
β¯b =
βbRtot
µb
, 1 =
αb
Ktotµb
, 2 =
αb
Rtotµb
, θ¯b = θbZtot,
δ¯z =
δzKtot
µb
, ρ¯z =
ρz
µb
, θ¯z = θzKtot.
D Rigorous Reduction of the Model for GA Signalling Pathway
from [36]
Here we present the rigourous reduction of the model for the GA signalling pathway from [36] to the
system of ODEs (10) and (11) for GA, GID1, DELLA, GA.GID1o, GA.GID1c, DELLA.GA.GID1c,
GID1m and DELLAm. To do this we assume that the dynamics of the actual biosynthesis may
be captured from the DELLA dynamics only. We also assume only one functional form of the
DELLA.GID1.GA complex. To save space we denote the independent variables by xi for i = 1, ..., 21,
in the same order as the full statement of the model in [36].
To describe GA signal transduction:
dx1
dt
= −lax1x11 + ldx2 + δgid1x20 − µgid1x1, (35a)
dx2
dt
= lax1x11 − ldx2 + px3 − qx2, (35b)
dx3
dt
= −px3 + qx2 − (ua1 + ua2)x6x3 + (ud1 + um)x4 + ud2x5, (35c)
dx4
dt
= ua1x6x3 − (ud1 + um)x4, (35d)
dx5
dt
= ua2x6x3 − ud2x5, (35e)
dx6
dt
= −(ua1 + ua2)x6x3 + ud1x4 + ud2x5 + δdellax21. (35f)
To describe GA biosynthesis:
dx7
dt
= ωga12 − ka12x7x16 + kd12x12 − µgax7, (36a)
dx8
dt
= −ka15x8x16 + kd15x13 + km12x12 − µgax8, (36b)
dx9
dt
= −ka24x9x16 + kd24x14 + km15x13 − µg1x9, (36c)
dx10
dt
= −ka9x10x17 + kd9x15 + km24x14 − µgax10, (36d)
dx11
dt
= Pmem
Sroot
Rroot
(A1ωga4 −B1x11) + km9x15 − lax1x11 + ldx2
− µgax11. (36e)
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To describe complexes of GAs and enzymes:
dx12
dt
= ka12x7x16 − (kd12 + km12)x12, (37a)
dx13
dt
= ka15x8x16 − (kd15 + km15)x13, (37b)
dx14
dt
= ka24x9x16 − (kd24 + km24)x14, (37c)
dx15
dt
= ka9x10x17 − (kd9 + km9)x15. (37d)
To describe the enzymes:
dx16
dt
= −ka12x7x16 − ka15x8x16 − ka24x9x16 + (kd12 + km12)x12
+ (kd15 + km15)x13 + (kd24 + km24)x14 + δga20oxx18
− µga20oxx16, (38a)
dx17
dt
= −ka9x10x17 + (kd9 + km9)x15 + δga3oxx19 − µga3oxx17. (38b)
To describe the mRNAs:
dx18
dt
= φga20ox
(
x6
x6 + θga20ox
− x18
)
, (39a)
dx19
dt
= φga3ox
(
x6
x6 + θga3ox
− x19
)
, (39b)
dx20
dt
= φgid1
(
x6
x6 + θgid1
− x20
)
, (39c)
dx21
dt
= φdella
(
θdella
x6 + θdella
− x21
)
. (39d)
We set Eq (35e) to zero since we assume that only one configuration of the DELLA.GID1c.GA4
can form. Since the conversion of GA4 precursors occurs on a relatively fast scale we set the time-
derivatives in (36a)-(36d) and (37a)-(39b) equal to zero. We immediately remove 3 variables by noting
from Eqs. (35e), (39a) and (39b) that
x5 =
ua2
ud2
x6x3, (40a)
x18 =
x6
x6 + θga20ox
, (40b)
x19 =
x6
x6 + θga3ox
, (40c)
and further from Eqs. (36a)-(36d), and (37a)-(38b) that
x16 =
δga20ox
µga20ox
x6
x6 + θga20ox
, (41a)
x17 =
δga3ox
µga3ox
x6
x6 + θga3ox
, (41b)
km9x15 = ωga12 − µga(x7 + x8 + x9 + x10), (41c)
with
x7 =
ωga12
µga +K12
, (42a)
x8 =
ωga12K12
(µga +K12) (µga +K15)
, (42b)
x9 =
ωga12K12K15
(µga +K12) (µga +K15) (µga +K24)
, (42c)
x10 =
ωga12K12K15K24
(µga +K12) (µga +K15) (µga +K24) (µga +K9)
, (42d)
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where
K12 =
δga20oxka12km12
µga20ox(kd12 + km12)
x6
x6 + θga20ox
,
K15 =
δga20oxka15km15
µga20ox(kd15 + km15)
x6
x6 + θga20ox
,
K24 =
δga20oxka24km24
µga20ox(kd24 + km24)
x6
x6 + θga20ox
,
K9 =
δga3oxka9km9
µga3ox(kd9 + km9)
x6
x6 + θga3ox
.
Substituting these into Eq.(41c)
km9x15 = ωga12
〈
1− µga

 (µga +K15) (µga +K24) (µga +K9)+K12 (µga +K24) (µga +K9)
+K12K15 (µga +K9) +K12K15K24

(µga +K12) (µga +K15) (µga +K24) (µga +K9)

〉
= ωga12
K12K15K24K9
(µga +K12) (µga +K15) (µga +K24) (µga +K9)
,
which can be multiplied through by the Hill function denominators, and upon simplifying to fourth
order terms in x6 becomes
km9x15 = αg
x46
x46 + θga
,
where
αg =
ωga12δga3ox(δga20ox)
3ka12km12ka15km15ka24km24ka9km9
(µgaµga20ox(kd12 + km12) + δga20oxka12km12)×
×(µgaµga20ox(kd15 + km15) + δga20oxka15km15)×
×(µgaµga20ox(kd24 + km24) + δga20oxka24km24)×
×(µgaµga3ox(kd9 + km9) + δga3oxka9km9)

and
θga =
(
µ4gaθga3ox(θga20ox)
3µga3ox(µga20ox)
3(kd12 + km12)∗
∗(kd15 + km15)(kd24 + km24)(kd9 + km9)
)

(µgaµga20ox(kd12 + km12) + δga20oxka12km12)×
×(µgaµga20ox(kd15 + km15) + δga20oxka15km15)×
×(µgaµga20ox(kd24 + km24) + δga20oxka24km24)×
×(µgaµga3ox(kd9 + km9) + δga3oxka9km9)

.
Thus, we obtain a reduced model that reads
dx1
dt
= −lax1x11 + ldx2 + δgid1x20 − µgid1x1, (43a)
dx2
dt
= lax1x11 − ldx2 + px3 − qx2, (43b)
dx3
dt
= −px3 + qx2 − (ua1 + ua2)x6x3 + (ud1 + um)x4, (43c)
dx4
dt
= ua1x6x3 − (ud1 + um)x4, (43d)
dx6
dt
= −ua1x6x3 + ud1x4 + δdellax21, (43e)
dx11
dt
= Pmem
Sroot
Rroot
(A1ωga4 −B1x11) + αg x
4
6
x46 + θga
− lax1x11
+ ldx2 − µgax11, (43f)
dx20
dt
= φgid1
(
x6
x6 + θgid1
− x20
)
, (43g)
dx21
dt
= φdella
(
θdella
x6 + θdella
− x21
)
. (43h)
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E Non-dimensionalisation of the model including spatial hetero-
geneity in the crosstalk signalling
Again applying scaling and non-dimensionalising via t = t∗t¯ etc, system (15)-(19) transforms into
∂t¯b¯ =
Dbt
∗
(x∗)2
∂2y b¯− µbt∗b¯
∂t¯k¯ =
Dkt
∗
(x∗)2
∂2y k¯
∂t¯z¯p =
Dzt
∗
(x∗)2
∂2y z¯p
∂t¯g¯ =
Dgt
∗
(x∗)2
∂2y g¯ − µgt∗g¯

in Ω¯c,
and receptor based interactions of BR, BKI1 and BRI1 and influx of exogenous GA occur on the
plasma membrane
−Dbt
∗
(x∗)2
∂y b¯ =
βkt
∗r∗bk
∗
x∗b∗
r¯bk¯ − βbt
∗r∗k
x∗
r¯k b¯
−Dkt
∗
(x∗)2
∂yk¯ =
βbt
∗r∗kb
∗
x∗k∗
r¯k b¯− βkt
∗r∗b
x∗
r¯bk¯
−Dzt
∗
(x∗)2
∂y z¯p = 0
−Dgt
∗
(x∗)2
∂y g¯ = 0
dr¯k
dt¯
=
βkr
∗
bk
∗t∗
r∗k
r¯bk¯ − βbb∗t∗r¯k b¯
dr¯b
dt¯
=
βbr
∗
kb
∗t∗
r∗b
r¯k b¯− βkk∗t∗r¯bk¯

on Γ¯c.
We assume that production of BR, change in phosphorylation status of BZR and interactions between
BZR and DELLA occur in the nucleus
Dbt
∗
(x∗)2
∂y b¯ =
lcαbt
∗
1 +
(
θbz∗z¯
lc
)hb
Dkt
∗
(x∗)2
∂yk¯ = 0
dz¯
dt¯
=
lcδzt
∗z∗pk∗
z∗
z¯pk¯ − ρzt∗ z¯
1 + (θzk∗k¯)hz
− βzt
∗
lc
z¯d¯l +
γzz
∗
dt
∗
z∗
z¯d
Dzt
∗
(x∗)2
∂y z¯p = − lcδzt
∗k∗
x∗
z¯pk¯ +
ρzz
∗t∗
x∗z∗p
z¯
1 + (θzk∗k¯)hz

on Γ¯n.
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We assume all constituent processes of the GA signalling pathway apart from degradation and influx
of GA also occur in the nucleus
dr¯
dt¯
= − βgt∗g∗r¯g¯ +
γgr
o∗
g t
∗
r∗
r¯og +
lcαrt
∗
r∗
r¯m − µrt∗r¯
dr¯og
dt¯
=
βgr
∗g∗
ro∗g
r¯g¯ − (γg + λc)t∗r¯og +
λorc∗g t∗
ro∗g
r¯cg
dr¯cg
dt¯
=
λcro∗g t∗
rc∗g
r¯og − λot∗r¯cg −
βdd
∗
l t
∗
lc
d¯lr¯
c
g +
(γd + µd)r
∗
dt
∗
rc∗g
r¯d
dr¯d
dt¯
=
βdd
∗
l r
c∗
g t
∗
lcr∗d
d¯lr¯
c
g − (γd + µd)t∗r¯d
dd¯l
dt¯
=− βdr
c∗
g t
∗
lc
d¯lr¯
c
g +
γdr
∗
dt
∗
d∗l
r¯d +
lcαdt
∗
d∗l
d¯m − βzz∗t∗z¯d¯l + γzz
∗
d
d∗l
z¯d
Dgt
∗
(x∗)2
∂y g¯ =
lcαgt
∗
x∗g∗
(
d¯l +
φzz∗
d∗l
z¯
)4
l4cϑg
(d∗l )
4 +
(
d¯l +
φzz∗
d∗l
z¯
)4 − βgr∗t∗x∗ r¯g¯ + γgro∗gx∗g∗ r¯og
dr¯m
dt¯
=φrt
∗
(
d¯l
lcθr
d∗l
+ d¯l
− r¯m
)
dd¯m
dt¯
=φdt
∗
 θdd∗l
θd
d∗l
+ d¯l
− d¯m


on Γn.
Finally we assume cross-talk via formation of the BZR.DELLA complex also occurs in the nucleus
dz¯d
dt¯
=
βzz
∗d∗l
z∗d
z¯d¯l − γzt∗z¯d on Γn.
We set
t∗ =
1
γz
, x∗ = lc, b∗ =
αb
µb
, k∗ = Ktot, r∗k = lcRtot,
r∗b = lcRtot, z
∗ = lcZtot, z∗p = Ztot, r∗ =
lcαr
µr
, ro∗g =
lcαr
µr
,
rc∗g =
lcαr
µr
, r∗d =
lcαr
µr
, d∗l =
lcαd
µd
, g∗ =
αg
µg
, z∗d = lcZtot,
and introduce the new dimensionless parameters
D¯b =
Db
γcl2c
, D¯k =
Dk
γZ l2c
, D¯z =
Dz
γzl2c
, D¯g =
Dg
γzl2c
,
µ¯b =
µb
γz
, µ¯g =
µg
γz
, β¯k =
βkRtotKtotµb
γzαb
, β¯b =
βbRtot
γz
,
1 =
αb
µbKtot
, 2 =
αb
µbRtot
, θ¯b = θbZtot, δ¯z =
δzKtot
γz
,
ρ¯z =
ρz
γz
, θ¯z = θzKtot, β¯z =
βzαd
γzµd
, β¯g =
βgαg
γzµg
,
γ¯g =
γg
γz
, µ¯r =
µr
γz
, λ¯c =
λc
γz
, λ¯o =
λo
γz
,
β¯d =
βdαd
γzµd
, γ¯d =
γd
γz
, µ¯d =
µd
γz
, 3 =
αrµd
µrαd
,
4 =
Ztotµd
αd
, ϑ¯g =
ϑgµ
4
d
α4d
, 5 =
αrµg
µrαg
, φ¯r =
φr
γz
,
ϑ¯r =
ϑrµd
αd
, φ¯d =
φd
γz
, ϑ¯d =
ϑdµd
αd
.
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Neglecting ¯ s we write out the non-dimensionalised PDE-ODE system, with diffusion and hormone
degradation occurring in the cytoplasm
∂b
∂t
= Db∂
2
yb− µbb
∂k
∂t
= Dk∂
2
yk
∂zp
∂t
= Dz∂
2
yzp
∂g
∂t
= Dg∂
2
yg − µgg

in Ωc. (44)
Receptor binding and dissociation occurring on the plasma membrane
−Db∂yb = βkrbk − βbrkb
−Dk∂yk = 1 (βbrkb− βkrbk)
−Dz∂yzp = 0
−Dg∂yg = 0
drk
dt
= 2 (βkrbk − βbrkb)
drb
dt
= 2 (βbrkb− βkrbk)

on Γc. (45)
The BR signalling processes occurring in the nucleus
Db∂yb =
µb
1 + (θbz)hb
Dk∂yk = 0
dz
dt
= δzzpk − ρz z
1 + (θzk)hz
− βzzdl + zd
Dz∂yzp = −δzzpk + ρz z
1 + (θzk)hz

on Γn. (46)
The GA signalling processes occurring in the nucleus
dr
dt
= −βgrg + γgrog + µr(rm − r)
drog
dt
= βgrg − (γg + λc)rog + λorcg
drcg
dt
= λcrog − λorcg − βddlrcg + (γd + µd)rd
drd
dt
= βddlr
c
g − (γd + µd)rd
ddl
dt
= 3
(−βddlrcg + γdrd)+ µddm − 4 (βzzdl + zd)
Dg∂yg = µg
(dl + 4φzz)
4
ϑg + (dl + 4φzz)
4 − 5
(
βgrg + γgr
o
g
)
drm
dt
= φr
(
dl
ϑd + dl
− rm
)
ddl
dt
= φd
(
ϑd
ϑd + dl
− dm
)

on Γn. (47)
The crosstalk interactions occurring in the nucleus
dzd
dt
= βzzdl − zd on Γn. (48)
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